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The CCAAT/Enhancer-Binding proteins (CEBPs) are liver-enriched transcription 
factors which are known to tram-activate a number of metabolically important genes. The 
goal of this thesis work has been to advance areas of study on CEBP isoform regulation 
and metabolic roles which have not been fidly addressed in the current literature. 
The initial undertaking of this work involved the examination of the effects of 
hormones and diabetes on CEBP isoform expression in rat H4IIE hepatoma cells and in 
rat liver. Treatment of cells with dexarnethasone was observed to produce increases in 
C/EBPa and C/EBPP mRNA and protein levels. Insulin was observed to produce an 
interesting bi-phasic response on CIEBPa expression. Treatment of H4IIE cells with 8- 
chlorophenylthio-CAMP produced greater inductive effects upon C/EBPP expression than 
on C/EBPa expression. We observed an inhibition of CEBPa gene expression in 
streptozotocin-diabetic rat liver which was reflected by decreases in both its mRNA and 
protein. However, an interesting alteration in the ratio of alternate C/EBPa translation 
forms was observed in the streptozotocindiabetic livers suggesting a potential alteration 
in the tram-activational activity of C/EBPa. These results suggest that hepatic CEBP 
isoforms are under complex control by both hormonal and metabolic signals, which 
correlates well with their known role as tram-activators of metabolically vital genes. 
Previous work has demonstrated a role for CEBPa in mediating the CAMP 
responsiveness of synthetic phosphoenolpyruvate carboxykinase (PEPCK) promoter 
constructs within a transiently transfefted cell culture system. In order to a d h  the 
-. 
-11- 
CEBP isofom requirements for endogenous PEPCK gene expression and regulation, we 
have produced stable transfected hepatoma cells expressing antisense constructs for the two 
major C/EBP isoforms in liver. We demonstrate that targeted inhibition of CEBPa but 
not C/EBPP in rat hepatoma H4UE cells significantly reduces the CAMP responsiveness 
of the endogenous PEPCK promoter. Cells expressing C/EBPa antisense were 
characterized by decreases in the levels CEBPa mRNA and C/EBPa protein levels. The 
response of PEPCK to CAMP was marginal in C/EBPa antisense expressing cells, 
compared with a 3-fold induction of PEPCK expression by CAMP observed in wild-type 
H4IIE cells. The CAMP signaling pathway of C/EBPa antisense expressing cells was 
intact in that the CAMP induction of the C/EBPQ gene was similar to that of normal H4IIE 
cells. Furthermore, the CAMP responsiveness of PEPCK in C/EBPP antisense expressing 
cells was nearly identical to that of wild-type H4IIE cells. These data suggest that the a- 
isoform of CEBP is specifically required for mediation of the CAMP response of 
endogenous PEPCK in rat hepatoma cells and cannot be functionally substituted for by 
C/EBPP in this context. 
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1. INTRODUCTION 
The regulation of gene expression in higher organisms is a complex biological 
process. Multi-cellular organisms are capable of both intra- and extra-cellular 
communication which can serve as the cue for modulation of gene expression. The ability 
of higher eukaryotes to modulate their patterns of gene expression in cell-specific fashion 
in response to physiological signals sets them apart h r n  single cellular organisms in the 
complexity oftheir behavior, and of course, the complexity of their regulatory mechanisms. 
This work deals with several nuclear transcription factors known as the 
CCAAT/Enhancer-Binding proteins (CEBPs), more specifically, the a and p-isoforrns 
which are highly expressed in liver. Given that CEBP isoforms play an important role in 
the hormonal regulation of a number of metabolically relevant genes, it stands to reason 
that they might also be honnonally regulated. The initial purpose of this thesis was to 
define the effects of a number of hormones upon CEBP isoform expression both in cell 
culture, and to what extent was possible, in vivo. During the course of this initial work it 
became apparent that C/EBPa played a vital role in mediating the CAMP responsiveness 
of phosphoenolpymvate carboxykinase (PEPCK) gene promoter constructs in human 
hepatoma cells (Roesler, ei al., 1996). The objectives of this research project then 
expanded to address the role of CEBP isoforms in the CAMP responsiveness of PEPCK 
gene expression in the intact hepatoma cell, utilizing both antisense and dominant negative 
inhibitor methodologies to this end. As the results of this research will show, CEBP 
isofonn expression is regulated by a number of metabolically relevant hormones in liver, 
and C/EBPa is vital for the mediation of CAMP responsiveness of the PEPCK promoter. 
In order to appropriately consider the relevant literature prior to demonstrating the 
results of this work, section 2 of  this document will first consider the basic concepts of 
transcriptional regulation of gene expression (section 2.1). Section 2.2 will deal with 
hormonal regulation over a gene's promoter in greater depth, using the PEPCK promoter 
as a relevant example. Section 2.3 will deal with CEBP in detail, in terms of its 
biochemistry, tissue specific and hormonally regulated expression, and its physiological 
roles. The following section (2.4) will deal with the background knowledge concerning 
the utilization of antisense constructs and dominant negative inhibitors to modulate 
transcription factor firnction. Finally, section 2.5 will describe the specific objectives of 
this research project. 
2. REVIEW OF THE LITERATURE 
2.1 Regulation of Gene Expression 
2.1.1 Overview of Transcriptional Regulation (cis and trons) 
Ultimately, it is the initiation of messenger RNA (mRNA) synthesis by RNA 
polymerase II (RNA pol 11) in mammalian systems which is a main control point for the 
regulation of gene expression. From a basic viewpoint, adaptive changes in expression of 
a given gene induced by relevant physiological stimuli, result from the interaction of an 
enormous group of nuclear proteins known as transcription faftors, or rum-acting factors, 
with specific regions or ciselements, of a gene's promoter. Spatially, eukaryotic cis- 
elements for RNA pol I1 transcribed genes can be located either upstream or downstream 
of the transcriptional initiation site. The location, number and arrangement of the cis- 
elements varies from gene to gene. It is the character and arrangement of the cis-elements 
which can define the possible forms of regulation over a given gene. DNA cis-elements 
serve as the binding or nucleation sites for groups of transcription factors which via protein 
- protein interactions, potentially with the RNA pol 11 complex itself, effect either 
positively, or negatively, the rate of transcriptional initiation. 
The cis-elements of the promoter region of most sequenced genes occur within the 
first 1000 base pairs (bp) of the transcriptional start site. Cis-elements located at greater 
distances (greater than 1 OOO bp, and up to perhaps even 30 kilobase pairs (kb)), and which 
can carry out regulation in an orientation - independent manner are by convention known 
as enhancer elements. Refer to Figure 2.1 for a diagram of a basic promoter. 
Potentially, tram-fx tors binding to remote enhancer elements might still interact 
with other fwtors binding to the main promoter, or with the RNA pol I1 complex directly 
by DNA bending. Certain ciselements are common to many pol II transcribed genes, for 
example GC and CCAAT boxes and the TATA element. Other cis-elements will be 
present based on the nature of the regulatory properties of the gene. OAen, certain cis- 
elements correspond to a "consensus sequence" for binding of transcription factors 
involved in specific forms of signal-transduced regulation. However, although factors 
which participate in certain forms of stimuli may bind a given consensus sequence, they 
are not limited to binding this sequence alone. In other words, the concept of conseasus 
sequence might be incorrect in that it is not the case that only certain tram-factors bind 
certain cis-elements. The actual situation has proven to be far more complex, since 
numerous exampies have shown that transcription factor association with a given cis- 
element is often mediated by other factors via protein-protein interactions. In fact, multiple 
factors may bind the same DNA sequence, producing a competitive phenomenon, and 
some fram-factors may not bind DNA at all but associate only with other directly bound, 
or otherwise interacting factors. It also appears to be the case that some signals, 
particularly those generated by certain hormones, are often mediated through a number of 
factors binding to multiple promoter elements (for reviews see Lucas and Gramer, 1992 
and Roesler and Park, 1998). 
Figure 2.1 Basic schematic diagram of a hypothetical TATAumtaining 
promoter showing general transcription factors (including TFIID, composed 
of the TATA-binding protein (TBP) and associated TAFs, and other general 
transcription factors including TFIIA, TFIIB, TFIIF, TFIIE and TFIIH) 
clustered around and/or in contact with RNA polymerase II (RNA pol II), 
forming the pre-initiation complex. DNA binding fa~tor A is affecting 
transcription through direct interaction with the pre-initiation complex. 
Transcription is further affected by the influence of DNA bound factor B, and 
the co-fxtor C which is physically linking the two DNA-bound factors and 
the pre-initiation complex with the aid of DNA looping. 
Transcription factors are for the most part, but not always, sequence specific DNA 
binding proteins. These factors are expressed in low abundance in the nucleus, although 
certain factors are known to be localized to the nucleus only upon being exposed to an 
appropriate physiological signal (considered by Vandro~nme, et a[. 1996), for example 
CIEBPP is known to translocate from the cytoplasm to the nucleus upon an increase in the 
intracellular levels of CAMP in rat PC 12 cells (Metz and Ziff, 1991). In general, 
transcription factors can be thought of as being modular in nature, composed of sejxuable 
DNA binding and transcriptional activation domains. 
DNA biding domains are quite compact, usually consisting of less than 100 amino 
acids. The four most commonly identified DNA binding motifs are the leucine zipper - 
basic region (bZIP) motif, the zinc finger, the helix - loop - helix motif, and the 
homeodomain motif (Mitchell and Tjian, 1989). As the bZIP motif was first characterized 
h m  analysis of the DNA binding domain of the CCAAT/Enhancer-Binding protein 
(Johnson, et al. 1987), in which this thesis is primarily concerned, we shall consider it in 
some detail at this point. Quite simply, the basic region - leucine zipper consists of a 
bipartite region of sequence; a stretch of approximately 30 amino acids which has an 
overall net basic charge, followed by a amino acid sequence which possesses a heptad 
repeat of leucine residues. This " leucine zipper" is required for dimerization among 
certain bZIP family members, as well as for DNA binding (Landschultz, et al. l988b). The 
dimerization between two monomers is thought to be stabilized by hydrophobic 
interactions between opposing a-helical regions of the leucine repeats in a matter 
analogous to the formation of quaternary coiled-coils (Crick, 1953) by such proteins as 
keratin and myosin heavy chain. Cross dimerization can occur between divergent members 
of the bZIP family, however the nature of the interactions are based on leucine zipper 
homology and the effects of covalent modification. For example, C/EBPa and CEBPP 
(LAP) share considerable sequence homology in their DNA binding and dimerization 
domains and are known to form heterodimers in vitro (Williams, et al. 1991), and may 
also form covalently linked dimers by disulfide bonding concomitant with the formation 
of the coiled-coil. The ability of bZIP family members to cross-dirnerize allows for an 
exponential increase in the combinations of possible DNA binding specificities, as well as 
tram-activational properties, from a limited set of nuclear proteins. Section 2.3.1.1 of this 
thesis will deal with the basic region - leucine zipper domain of C/EBP in greater detail. 
Much like DNA-binding domains, activation domains are normally relatively short 
segments of primary sequence, usually less than 100 amino acids in length. Many factors 
are known to have more than one activation domain, and these separate domains may often 
act in synergy with one another, whereas, an isolated activation domain may have little, if 
any, tram-activational capability. The three main activation domains which have been 
identified in the majority of tram-acting factors are the acidic - a-helical, glutaxnine-rich, 
and proline-rich motifs (Ptashne, 1988). The general consensus is that these regions 
exhibit their fimctionality by making contacts with other proteins, presumably with 
members of the general pre-initiation complex (the general transcription fsctors or GTFs), 
and then in some manner stabilize interactions with DNA or with other proteins, and 
thereby favor the initiation of transcription. The tram-activation domains of C/EBP will 
be discussed in fkther detail in section 2.3.1.2. 
2.13 Hormone Ruponse Units 
The overall organization of cis-elements, with which trans-acting factors relevant 
to the mediation of a given hormonal signal associate with, have come to be known as 
hormone response units (HRUs) (Lucas and Granner, 1992). However, this statement in 
itself is somewhat too simplistic, as many metabolically important gene products are 
known to be regulated via integration of a number of different physiological stimuli. 
Nevertheless, because of the complex nature of HRUs, they can allow both negative 
cooperativity, and synergy between different signaling pathways (Roesler and Park, 1 998). 
This convergence of multiple signaling pathways allows for a higher order of regulation. 
Hormonal response units typically consist of one or more recognizable hormone response 
elements (HREs) as well as a number of accessory elements (AE's). In general, a HRE in 
isolation is able to mediate a recognizable transcriptional effect in response to a relevant 
hormonal signal. However, this is usually not the case for AE's in isolation; rather AE's 
would seem to confer amplification or even pennissivity to the transcriptional response. 
As reviewed by Lucas and Granner ( 1  992), HREs and AEs taken together as a HRU allow 
for mechanisms to modulate the specificity, magnitude, and positive or negative polarity 
of a transcriptional response. In the next section (2.2) we will discuss in detail an example 
of a complex hormonally regulated gene promoter, the PEPCK promoter, upon which a 
significant portion of the work of this thesis resides. 
2.2 The PEPCK Gene Promoter, a Paradigm of Hormoaally Reguiated Gene 
Expression 
PEPCK is generally considered to be the rate-limiting enzyme of gluconeogenesis 
(Rognstad, 1979). The PEPCK enzyme catalyzes the conversion of oxdoacetate to 
phosphoenolpyruvate and CO,, requiring guanosine triphosphate as a wfactor: 
> PEP + GDP + CO, Oxaloacetate + GTP <- 
Two forms of PEPCK enzyme exist. The mitochondria1 form (PEPCK-M) is 
constitutively expressed and is the form predominantly active when lactate is used as a 
gluconeogenic precursor (Hanson and Patel, 1994). The cytosolic form (PEPCK-C) is 
under hormonal regulation, and is rather unique amongst the majority of regulatory 
enzymes in that it has no known allosteric modifiers. For this reason, control of gene 
transcription plays the predominate role in regulating PEPCK-C's level of cellular activity. 
It should be noted that two separate genes encode PEPCK-C and PEPCK-M, each with its 
own unique promoter region. The work described in this thesis deals only with the effects 
on the promoter of PEPCK-C. 
2.2.1 Tissue-Specific Expression of PEPCK-C 
The cytosolic form of PEPCK is expressed mainly in the liver and kidney, the two 
primary gluconeogenic tissues. However, expression is also detected in non-gluconeogenic 
tissues such as small intestine, lung, mammary gland, and white and brown adipose 
(Ballard, et al. 1 967; Anderson, 1 970; Feldman and Hirst, 1978; Lobato, et al. 1985 and 
Zimrner and Magnuson, 1990). Presumably, PEPCK can be involved in glycerol sythesis 
during starvation via a process known as glyceroneogenesis as first described by Ballad, 
et al. (1 967). Even during the net lipolysis which occurs during starvation, a certain level 
of triglyceride synthesis is required and PEPCK may act to ultimately produce 3- 
phosphoglycerate which can be utilized in the re-esterification of fke fatty acids. PEPCK- 
C expression in kidney has a dual role due to the symbiotic relationship between 
gluconeogenesis and ammoniagenesis in this tissue during starvation (Alleyne, et al. 1969 
and Pitts, 1974). A metabolic acidosis often results during starvation and this pH 
imbalance can be offset by ammonia production via the interconversion of glutatnine to a- 
ketoglutarate. The a-ketoglutarate produced can be converted to oxdoacetate which is 
utilized by PEPCK to ultimately produce glucose, which is also required in the starvation 
state. 
2.2.2 Physiological Factors Which Effect PEPCK-C Gene Expression in Liver 
PEPCK expression can be modified by a number of influences, including diet, 
oxidation-reduction state (Hellkarnp, et al. 1 99 1 and Kietzmann, et al. 1 W2), physiological 
states such as starvation or diabetes, and the direct effects of various hormones including 
glucagon (via CAMP), glucocorticoids, thyroid hormone, and insulin. Correspondingly, 
PEPCK transcription in liver is upregulated when physiological stimuli indicate that 
increased glucose production is required, such as during starvation (Kioussis, et al. 1978), 
by metabolic aberration during diabetes (Sasaki, et al. I984 and Friedman, et al. 1993), or 
in response to increasing levels of glucagon (Tilghman, ef af. 1974) or glucocorticoids 
(Alleyne, et a/. 1969). PEPCK transcription is strongly down-regulated by insulin 
(Tilghman, et al. 1974), prolonged high-carbohydrate diet (Lamers, er al. 1982)- glucose 
(Kahn, et al. 1989 and Meyer, et al. 199 l), and by a number of other compounds such as 
serotonin (Zabala, et al. 1992) and phorbol esters (O'Brien, et al. 1991). 
2.2.3 Transcriptional Regulation of the PEPCK-C Gene 
It should be understood that aside from the majority of regulation of PEPCK-C 
expression which occurs at the level of its transcription rate there is also some degree of 
control over the stability of its mRNA. PEPCK-C mRNA is rapidly degraded with a half- 
life of approximately 30 minutes (Nelson, et al. 1980). The rnRNA of PEPCK can be 
stabilized by binding of a hepatocyte enriched protein to its 3' un-translated region. The 
levels of this protein are induced in liver in response to fasting (Nachaliel, et ul. 1993). 
The half-life of PEPCK-C mRNA is also known to be extended to nearly 4 hours by the 
influence of a CAMP analogue (Hod and Hanson, 1988). These factors taken together 
suggest a mechanism for sustaining PEPCK mRNA levels and enzyme activity during the 
initial stages of stsuvation, and or in response to increased levels of CAMP. 
2.23.1 The Hormonal Response Units of the Rat PEPCK-C Promoter 
The majority of  hormonal response units present in the rat PEPCK-C gene promoter 
can be found within the first 500 bp upstream of the transcriptional start site. To date, 
eleven distinct cis-elements have been identified within this region and are known to bind 
a multitude of liver expressed factors (See Figure 2.2 and Table 2.1 for summary). 
Outlying regions at -987 and -660 bp of the rat PEPCK-C promoter has been elucidated 
to be a peroxisome-proliferator-activated-receptor esponse elements (PPARREs), and are 
known to bind heterodimers of the peroxisome-proli ferator-acti~ated~receptor iso form y, 
(PPARyd and the retinoid-X receptor a-isoform (Tontonoz, et al. 1995). Overexpression 
of these factors, even in a non-adipose background, in the presence of promoter constructs 
containing the PPARE can lead to significant activation of PEPCK gene expression. 
In the following sections we will consider the individual hormonal response units 
of the PEPCK-C promoter. 
2.2.3.1.1 The Clucocorticoid Response Unit 
Interestingly, while the PEPCK-C promoter is activated by glucocorticoids in liver 
(Meisner, et al. 1 985) and inhibited in adipose tissue (Nechushtan, et ul. 1 987), there are 
no "consensus" glucocorticoid response elements present within the promoter. There are 
however, two sites which bind the glucocorticoid receptor (GR), known as GRE-1 and 
GRE-2 (Refer to Table 2.1). These dual response elements bind the glucocorticoid 
receptor weakly and are not sufficient to mediate the full transcriptional response of the 
Table 2.1. Regulatory cis-elements of the PEPCK-C promoter 
I Binding Site / Location Sequence / Binding Protein(s) )---..-....-.......--..-....--.....+.-.---..--.------.---..--...-.f***-.-*-.--* - *. -.*. .* .- *-.. * --.**. .- ......-.-.-----..--.--,.----...-...-.-..----------------.-.-....-.-.*--* 
j -9 1 / -84 i TTACGTCA i CRE-1 CREB, fodjun, 
i ATF-2, C/EBP 
I.-.- -----.-.....--..-.-.--------.-+----~.~..--..**.~*.....*.~~*..<..-*~-~.~~~....-..--~*~~~~..-~....*-..~.....~~..-....~~-.~~--..~--~.+*....*..-~....-.....--~.-*~*-...-..*~...-..-....~ 
CRE-2 / -1441-137 i TTAGGTCA i C/EBP 
! P2 -1901-185 ATTAAC ! HNF-1 
t- -.----.-.-----.-...-..----.--.-.-+.------------------.-----.-..- >-. -**....** -- --.*-.***.*..-..**-.--....-...~~~.~....-. -..--~~--.,..--.- .***.*.~~.~~--~---*-*.---.*---*.***..-.~~ ! 
-282 / -274 i AATCAGCAAC i CfEBP ; p4 
, --~..~*. . .~-~.. . . .~. .~~.. . . -- .~.~~+*~~.~~~..~.. . .~-. .~.~..~..~.~.~4444444..44444*44444444.4444444444..4.4.4444444444444444444444444444*..~.~..~.~~~.. .* .* .*~*~~~.~~~~~~*.~.~~..~**.~.. .  ? 
i GRE-l(P5) (-3851-374 i ACACAAAATGTG ! GR 
I..... .............................+..............................<....................................................................,................................................. ! 
i AF- I (P6) i -450 / -436 ATGACCmGGCCGT HNF-4, COUP-TF, 
j RARa 
................................... ~.----....-..-.-.........-..***~~.*.~~-..-~~.--..----*---...--.-...-.............-*..~~-~-..-.*.~~-.......*~*.-.*....--.~.--.~--*~.-~.-..~.........., 
This table is adapted from Liu and Hanson, 1991. 
CRU 
GRU ' LSR 
I 1  
Figure 2 3  Spatial arrangement of the ciselements of the rat PEPCK-C gene 
promoter. The following abbreviations are used: AF 1,  accessory factor 1 binding site; 
AF2/tRS, accessory factor 2 binding site / insulin response sequence; GRE, 
glucocorticoid response element; TRE, thyroid hormone response element; CRE, 
CAMP response element; GRU, glucocorticoid response unit; LSR, liver-specific 
region; CRU, CAMP response unit. This figure is adapted from Nizielski, el al. 
( 1 996). 
PEPCK-C promoter to glucocorticoids. They require the involvement of two accessory 
factor sites, AF- 1 and AF-2 (Insulin Responsive Sequence (IRS)), thus forming a complete 
glucocorticoid response unit (GRU) (Imai, er al. 1990). The AF-1 binding site is 
palindromic and consists of two half-sites, termed box b and c, which can senre as binding 
sites for hepatic nuclear factor - 4 (HNF-4) and the chicken ovalbumin upstream promoter - 
transcription factor (COUP-TF) (Hall, et a/. 1995), one of which may be bctionally 
redundant. The AF-1 site is also a retinoic acid response element (RARE), which can bind 
heterodimers of retenoic acid receptor a (RARa) and retenoid X receptor a m a )  (Hall, 
et ~1.1992). However, the glucocorticoid response of the PEPCK-C promoter does not 
seem to be effected directly by RARa. The AF-2 (IRS) site seems to play a dual role, 
being involved in mediating glucocorticoid responsiveness, and the negative effects of 
insulin as well (Imai, et al. 1 990 and 0' Brien, et al. 1 990). The IRS appears to be flanked 
on either side by binding sites for CEBP and HNF-3 (O'Brien, et ai. 1995 and O'Brien et 
al. 1 994 respectively); either of these factors may be involved in glucocorticoid induction 
or insulin repression, and in the case of C/EBP, may be involved in linking these responses 
to other signaling pathways, such as the synergistic induction of PEPCK with CAMP. 
Discussion of the role of the IRS in the negative regulation of PEPCK-C expression will 
be discussed further in section 2.2.3.1.4. 
2.23.1.2 The Thyroid Hormone Ruponsc Unit 
Only two cis-elements of the PEPCK-C promoter are required for M l  
responsiveness to thyroid hormone. The thyroid hormone receptor (TR) binds to the 
PEPCK thyroid response element (TRE) (Giralt, et ui. 1991) as a heterodimer with the 
retinoid X receptor (RXR) (Mangelsdorf, et at. Z 990 and 1995, and Schmidt, et a/. 1993). 
The second required element is the P3(l') element to which either the a or p-isofonns of 
C/EBP can bind and participate in the thyroid response of PEPCK-C (Park, et al. 1999). 
Again, as occurs in the glucocorticoid response unit, the presence of a CEBP isofom 
allows for synergism with the other response units of the promoter with which it interacts, 
potentiating the inductive effect upon PEPCK-C expression. 
2.23.13 The CAMP Response Unit 
The CAMP response unit of the PEPCK-C promoter consists of two independently 
weak elements, a CAMP response element (CRE- I), and an upstream liver-specific region 
(LSR) which contains binding sites for three CEBP molecules and one molecule of the 
fodjun heterodimer, AP 1 (Roesler, et al. 1994). The CAMP response element (CRE- I) 
of the PEPCK-C promoter was first described by Bokar, et al- (1988), and as reviewed by 
Roesler, et at- (1988), was observed to be quite similar in sequence to CREs of other 
CAMP responsive genes. It should be noted that a second putative CRE, CRE-2, is located 
45 base pairs upstream of CRE- 1 (Roesler, et af. 1989). However, CRE-2 is not thought 
to participate directly in the CAMP responsiveness of PEPCK-C in rat liver. Multiple bZIP 
transcription factor family members including the CAMP response element binding protein 
(CREB), CEBP isoforms, D-site binding protein (DBP), jun/jun homodimers, fosljun 
(AP 1) heterodimers, and activating transcription factor-2 (ATF-2) are known to bind the 
CRE-1 and induce PEPCK-C transcription in cyto (Quinn, et al. 1990; Park, et al. 1993, 
Roesler, et a/. 1992 and Cheong, et al. 1998). Initial affinity chromatography studies 
utilized to purifL factors which could bind the CRE- 1, revealed a 43-kDa protein which 
could correspond either to CREB or the a-isofom of CEBP (Roesler, et al. 1989). 
Further DNA-protein binding assays demonstrated that the affinity ofbinding to the CRE- 1 
was much higher for CEBPf.3 and CREB than was for CIEBPa (Park, et al. 1993). 
However, a recent study by Roesler, et al. (1998), has shown that the CAMP response of 
the PEPCK-C promoter can occur in the absence of CREB, and can be subsituted for by 
the a-isoform of C/EBP. Thus, there remains some controversy over the identity of the 
factor which binds CRE-I and mediates CAMP responsiveness. 
The upstream liver-specific region (LSR) of the PEPCK-C promoter was first 
described in detail by Roesler, et al. ( 1 994) and confirmed by Yeagley, et al. (1 9%). Much 
like the CRE-1 in isolation, the LSR ciselements are only capable of modulating a 
minimal response to CAMP by themselves; they rather serve to mediate the robust CAMP 
responsiveness of the PEPCK-C promoter by synergizing with the downstream CRE- 1. 
The LSR was so named because the number of tram-acting factors which can bind to its 
sequences are enriched in liver nuclear extracts, such as CEBP isofoms and the D-site 
binding protein. The LSR contains the originally described P(3) and P(4) ciselements, the 
aforementioned work by Roesler, et al. (1 994), has shown that the P(3) site is split into two 
half sites, known as the A and C sites or as P 3 0  and P30, respectively (refer to Table 
2.1). The C site binds C/EBP isoforms and along with the two other CEBP proteins 
binding to the P(4) region, are required for synergistic mediation of CAMP responsiveness 
along with CRE-1. The A site (P3(II)) serves to bind the fodjun heterodimer AP1, and 
appears to act to augment the synergism between the complete LSR and CRE- I, since the 
A site alone has essentially no ability to synergize with the CRE-1. It should be noted that 
the necessity of an AP-1 binding site has also been demonstrated within the CRUs of a 
number of other gene promoters including c-jtos (Fisc h, et al. 1 989) and the proenkephalin 
gene (Hyman, et a/. 1989). 
A final note in this brief primer on the CAMP response unit of the PEPCK-C 
promoter, is the potential existence of a "braking mechanism" over protein kinase A (PICA) 
inducible expression of the promoter, as provided by a specific Nuclear Factor I (NFI) 
isofonn, NFI-C (Crawford, et al. 1998). NFI, because of its inhibitory effects upon 
PEPCK-C basal, and PKA induced expression, may serve as a means to maintain lowered 
levels of PEPCK expression, thereby providing an additional level of negative control over 
hepatic glucose production. NFI binds to the PI site of the promoter in close proximity 
to the CRE-I; the results of Crawford, et al. (1998), show that NFI-C is capable of 
inhibiting CREB mediated induction of PEPCK activity in cyto. This result is certainly 
significant if CREB is in fact the tram-acting faetor which binds to the CRE-I in vivo and 
mediates CAMP responsiveness. 
2.23.1.4 Inhibition of PEPCK-C Expression by Insulin 
Insulin is a dominant negative inhibitor of basal (Granner, et al. 1983), CAMP 
and glucocorticoid induced (Sasaki, et al. 1984 and Granner, et al. 1992) expression of 
PEPCK-C in liver. An insulin responsive sequence (IRS) has been identified in the 
PEPCK-C promoter in the region from -420 to -402 (O'Brien, et al. 1990). The IRS 
corresponds to the AF2 site present in the glucocorticoid response unit (see section 
2.2.3.1. l), making elucidation of its role in PEPCK-C expression difficult, as mutation or 
deletion of this site effects both the inhibition by insulin, as well as the inductive effects 
of glucocorticoids (Fwrest, et al. 1 990). As mentioned in section 2.2.3.1.1 , the IRS is 
flanked by binding sites for CEBP and HNF-3, although neither of these sites are 
particularly similar to consensus. It may be the case that binding of a yet unknown factor 
to the IRS (an insulin response factor or IRF) may interfere with the subsequent binding 
of factors to either of these flanking sites, and bring about the inhibitory effects of insulin. 
However, such a model cannot account completely for the strong dominant negative effects 
of insulin, as wmplete deletion of the AF2 site only diminishes the glucocorticoid 
responsiveness of the PEPCK-C promoter by 50%; a complete inhibition, as is mediated 
by insulin in the intact promoter, is not observed. Considering these facts, it would seem 
that insulin likely mediates its effects at various points in the promoter, perhaps also 
indirectly effecting the DNA binding and or trans-activational capabilities of certain 
transcription factors. 
A recent report (Liao, et uf. 1998) demonstrated that the CAMP and glucocorticoid 
inducible expression of PEPCK-C could be directly inhibited by activation of a protein 
kinase B (PKBIAkt) construct in stable transfected rat hepatoma H4IIE cells. Protein 
kinase B is a downstream target of a number of phospholipid products of 
phosphatidylinositol 3-kinase (PI 3-kinase) (Toker, et uf. 1997), which itself is a 
downstream component of insulin signal transduction. The inhibition of CAMP and 
glucocorticoid responses by insulin has previously been shown to be mediated by the 
activation of PI 3-kinase (Sutherland, er 01. 1995). The report by Liao, ef al. (1998), is 
significant in that it suggests the ability to down-regulate induction of PEPCK-C 
expression by covaient modification, via PKB, of a variety of factors involved in the 
glucocorticoid and CAMP responses. 
23.4 The Effects of dioMes meIIirus  on PEPCK-C Gene Expression 
The expression of the cytosolic form of hepatic PEPCK-C is upregulated in 
virtuaily all known syndromes of diaberes rnellirus (Shrago, et al. 1963; Chang, et af. 1970; 
Veneziale, er al. 1 983 and Nandan, et ul. 1 993). As PEPCK-C is the rate-limiting enzyme 
of gluconeogenesis, an upregulation of its  activity in liver during diabetes can partially 
account for the prevailing hyperglycemia which is characteristic of  this group of 
syndromes. In fact, transgenic mice which over-express rat PEPCK-C are observed to be 
hyperglycemic and resistant to insulin (Valera, et al. 1994). However, to date human 
genetic linkage analysis has shown no association between the loci for PEPCK-C and non- 
insulin dependant diabetes mellitus (NDDM) or mature-onset diabetes of the young 
(MODY) (Vaxillair, et af. 1 994, Elbein, et al. 1 995 and Ludwig, et aZ. 1 9%). Potentially, 
the induction of PEPCK-C during diabetes may be due to the increased cAMP/iiulin ratio 
which exists in this state, which thereby results in increased hepatic glucose output 
(Unger, et al. 1 970; DeFronzo, et al. 1982; Baron, et al. 1987 and Consoli, et al. 1 990). 
However, work by Friedman, et al. (1993), utilizing transgenic mice to determine the 
regions of the PEPCK-C promoter active in its upregulation during diabetes, demonstrated 
that deletion of portions of the CRU had no effect upon the increased expression of the 
gene during diabetes, nor upon any subsequent down-regulation which could be effected 
by insulin. However, this work also revealed that diabetic transgenic mice possessing a 
deletion of the GRU within the PEPCK-C promoter - bovine growth hormone reporter 
constructs displayed no increase in reporter gene activity, suggesting a requirement of the 
GRU and glucocorticoids in mediating the upregulation of PEPCK-C during diabetes. 
This observation correlates nicely with the classical physiological studies by Long and 
Lukins, (1936) and by Houssay, (1942), who independently demonstrated the role of 
glucocorticoids in diabetic hyperglycemia Although deletion of the GRU in these 
transgenic mice also disrupts the proposed IRS, interestingly, nonnoglycemic individuals 
are still able to respond normally to high carbohydrate, suggesting that this response to 
carbohydrate is not mediated by insulin acting through the IRS alone, but perhaps through 
some other site. In fact this particular observation was W e r  supported by the work of 
Scott, el ui. (1 998) who demonstrated that glucose could directly inhibit PEPCK-C gene 
expression independently from insulin, potentially through a yet un-characterized 
carbohydrate responsive element (ChoRE). Carbohydrate responsive elements have been 
described in a number of other metabolically important genes. including the pyruvate 
kinase, and the 6-phosphohcto-2-kinase/fiuc tose-2,6-bisphosphatase genes (Towle, et al. 
1997 and Dupriex, et a]. 1997 respectively). 
An obvious short-coming of the work by Friedman, et al. (1993), involves the 
complications brought about by the intrinsic positioning of the IRS within the GRU, such 
that the observations made with respect to the glucocorticoid responsive regions must also 
take into consideration the loss of the putative [RS. Given that the IRS can only account 
for perhaps SO'?% of the insulin-mediated inhibition of PEPCK-C transcription, its 
disruption by deletion of the GRU may not significantly downplay the observed 
requirement of the latter in the diabetic induction of PEPCK-C expression. Despite some 
short-comings this work does however provide some interesting and novel insight into the 
malecular mechanisms behind the alterations in PEPCK-C gene expression which occur 
in diabetes. This aforementioned work has been expanded with use of a less potentially 
interfering C-reactive peptide reporter construct, again by Friedman, et al. (1997), who 
showed that in genetically obese and diabetic db/db mice, the proximal 460 bp of the 
PEPCK-C promoter, containing the GRU, is sufficient to mediate its upregulation during 
diabetes. Furthermore, this work provides supporting evidence regarding the requirement 
of glucocorticoids to mediate the diabetes-induced changes in expression of not only 
PEPCK-C, but other gluconeogenic enzymes as well. The results of this research also 
show that changes in PEPCK-C expression in the diabetic db/db mouse occur 
independently from events mediated through the IRS. 
Thus, the cwrent state of knowledge reveals a vital importance for glucocorticoids 
in the diabetic induction of PEPCK-C gene expression. Clearly, fiuther investigation into 
the tram-acting factors which mediate this potentially complicated response will prove 
invaluable, and may uncover interactions with other hormonal response units which are 
involved in this complex milieu of metabolic regulation. As a final consideration, even 
though the role of the CRS has been perbps down-played in this investigation of diabetes- 
induced changes in PEPCK-C expression, certainly acknowledgment of the role of insulin 
in this process cannot be neglected, and it seems likely that W e r  investigation may reveal 
aspects of its indirect effects at the point of the multiple nuns-acting factors which are 
components of the various hormonal response units of the PEPCK-C promoter. 
23 The CCMTfEnhancer-Binding Protein (CtEBP) 
The CCAATEnhancer-Binding protein or CEBP was first described as a heat- 
stable DNA-binding protein which was enriched in rat liver nuclei. This tram-acting 
factor demonstrated selective binding to the CCAAT homology sequence of a number of 
viral promoters (Graves, er al. 1986) and to the core homology of many viral enhancers 
(Johnson, ef al. 1987). Despite the rationale of naming this protein based on its binding 
affinity to viral control elements, over the subsequent years CEBP has been shown to play 
a pivotal role in mammalian metabolism. CEBP was first cloned h m  a rat liver cDNA 
library by Landschul~ el al. (1988a), in the laboratory of Steven L. McKnight. This work 
laid the foundation for years of fiuther characterization of this transcription factor, and 
provided the first bits of evidence which led to the discovery of the basic region - leucine 
zipper @ZIP) DNA-binding - dimerization motif, as well as the Scissors-Grip model of 
DNA binding. 
23.1 The Biochemistry of the CCAAT/Enhincer-Binding Protein 
The work of Graves, et al. (1 986) and Johnson, et al. (1987), noted above detected 
what were initially believed to be unique DNA-binding activities capable of interacting 
with either the CCAAT homologies of the herpes simplex virus thymidine b a s e  gene and 
Moloney murine sarcoma virus (MSV) left terminal repeat, or to the enhancer sequence, 
5'-TGTGGTAAG-3' of the MSV, SV40 and polyoma virus promoters. These DNA- 
binding activities where initially named as the CCAAT binding protein (CBP), and 
enhancer binding protein - 20 kDa (EBP-20), respectively. Both activities were heat-stable, 
which facilitated their purification from the majority of other cellular proteins and most 
DNA-binding activities, and both migrated as 20 kDa species on SDS-PAGE gels. Further 
study demonstrated that EBP-20 was capable of binding to CCAAT homologies in a 
manner indistinguishable from CBP, and this was the first indication that the two binding 
activities were actually arising from a single polypeptide species. Continued work by the 
McKnight group lead to the production of an antiserum against the CBP or EBP-20 binding 
activity, and eventually to the isolation of cDNA and genomic clones (Landshultz, et af. 
1988a). Analysis of the genomic clone revealed that the gene was intronless. Further 
analysis of the cDNA clone's open reading frame, and examination of rat liver nuclear 
extracts in the presence of protease inhibitors by Western immunoblotting revealed the true 
size of the intact polypeptide to be 42 kDa (the initial 20 kDa fonn was recognized to be 
a proteolytic degradation product). The cloned cDNA encoding for a polypeptide of 43- 
kDa which possessed DNA-binding properties of both CBP and EBP-20, was thereafter 
referred to as CEBP or the CCAAT/Enhancer-Bindhg protein. The DNA-binding activity 
of CEBP is localized to a 14-kDa fragment carboxy-terminal hgment, and a 60 amino 
acid segment within this fragment was observed to have considerable sequence similarity 
to regions of the Myc and Fos proteins. This conserved amino acid segment was later 
characterized as the leucine zipper - basic region @ZIP) motif (hdshultz,  et a!. 1 988b). 
2.3.1.1 The bZIP Domain of C/EBP 
Analysis of a 30 amino acid segment within C/EBP's DNA-binding activity 
revealed the potential for a a-helical conformation of this segment based upon a lack of 
he1 ix-breaking residues, and an abundance of charged residues. When the primary 
sequence of this segment was super-imposed upon an idealized helix it revealed the 
presence of a periodicity of leucine residues, one at every seven residues, spanning over 
eight helical turns (Landshultz, et al. 1 988b). The McKnight group demonstrated that the 
repeating leucine residues were arranged so as to form a hydrophobic strip down one side 
of the he1 ix (See Figure 2.3). They postulated that two separate molecules possessing such 
leucine rich amphipathic helices could potentially interact, or dimerize in a manner 
analogous to a coiled-coil, via hydrophobic interactions between their leucine rich 
hydrophobic strips. This dimerization motif was named the "leucine zipper". Further 
physical experimentation by McKnight and colleagues showed that the sequence-specific 
Figure 2.3. Helical Wheel analysis of 28 amino acids of the CEBP 
carboxy- terminus known to possess its dimerization capability. Standard 
one letter amino acid nomenclature is utilized. Most notable is the 
periodicity of leucine residues (L), corresponding to residues 1,8, 15 and 
22 of the segment analyzed. This strip of hydrophobic leucine residues or 
"leucine zipper" is proposed to act as a dimerization motif between 
separate polypeptides possessing similar leucine repeats, presumably via 
hydrophobic interactions. This figure is adapted from Landshultz, et of. 
(1 988b). 
interaction of C/EBP with DNA required the leucine zipper dimerization interface, as well 
as a DNA binding surface rich in positively-charged amino acids, which was named the 
basic region. Contact with DNA was seen to require the presence of the basic regions of 
two monomers brought into a functional conjunction by the interaction of their leucine 
zippers, thus the DNA binding domain was observed to be bipartite (Landshultz, et af. 
1989). The model of dimerization interaction predicted that the two leucine zippers of a 
potential dirner would dock in an orientation parallel to the dipoles of the helices. Such 
a manner of interaction would lead to a proximal opposition of the basic regions of the two 
monomers, such that the two basic regions might have to track around the DNA in opposite 
directions, thus requiring two half-sites with dyad symmetry in the DNA sequence. This 
hypothesis was confirmed by further work of this group, upon which they presented the 
"Scissors-Grip" model of DNA binding (Vinson, et al. 1989). Graphical representations 
of a leucine zipper - basic region motif making DNA contact via the "Scissors-Grip" can 
be seen in Fig. 2.4 and Fig. 2.5. The Scissors-Grip model required that the individual bZIP 
polypeptides wrap around DNA on the opposite side of the DNA to their initial approach. 
Such a model allowed for the positively-charged amino acid residues of the basic regions 
to localize to the edges of the major groove where they would be free to interact with the 
phosphodiester backbone. The leucine zipper and "Scissors-Grip" model have proven 
attractive concepts due to their allowance for the formation of heterodimers by 
polypeptides with similar bZIP domains; such an event allows for a great increase in the 
potential number of unique hybrid tram-activation activities which could make contact 
with a given dyad symmetric recognition sequence. 
Figure 2.4. A space- filling model representation of a hypothetical leucine 
zipper - basic region motif making contact with DNA via the "Scissors- 
Grip". The white backbone indicates the position of the dimerized 
polypeptides, each making contacts with DNA viu their basic regions. One 
polypeptide chain is contacting DNA into the plane of the page, the other 
chain is making contacts out of the plane of the page. This figure is 
adapted from the "lzip" graphic file found on the 
h t t ~ : / / w w . n c i . n i h . ~ o v / i n t r a / l m b / ~  web site. 
Figure 2.5. Artistic conception of a leucine zipper - basic region motif making 
contact with DNA via the "Scissors-Grip". Dimerization via the leucine zipper 
of each monomer is required for DNA binding by each basic region. The 
Scissors-Grip model allows the polypeptide chains to wrap around the DNA 
helix, bringing positively charged residues of the basic regions in contact with 
the phosphodiester backbone of DNA which is exposed in the major groove. 
This figure is adapted from "Molecular Zippers in Gene Regulation" by Steven 
Lanier McKnight, appearing in the April 1 99 1 issue of Scientific American. 
Each polypeptide of a heteroaimer is open to unique regulation over its DNA binding and 
tram-activational capabilities and thus allows for a corresponding increase in the 
possibilities for regulation of a gene's promoter with which it interacts. 
2.3.1.2 The Tram-Activation Domains of C/EBP Proteins 
The tram-activation domains of C/EBPa were first described by Pei and Shih, 
(1991)' who reported that the N-terminus of CEBP contained three distinct domains; an 
acidic tram-activator domain (amino acids 1 to 107)- a proposed attenuator domain (amino 
acids 107 to 1 70) and a second, somewhat weaker tram-activation domain extending h m  
amino acids 1 7 1 to 2 1 5 which was rich in proline residues. The nature of C/EBPa' s trans- 
activation domains were fiuther investigated by Nerlov and Ziff, (1 999, who demonstrated 
that two amino acid segments termed TE-I (amino acids 1 thru 70) and TE-I1 (amino acids 
70 thru 96) could cooperatively mediate binding to the TATA binding protein (TBP) and 
TFIIB, showing direct interaction between a transcription factor's tram-activational 
domains and members of the RNA pol I1 basal transcriptional apparatus. Recently, 
Roesler, et al. (1 998)' have shown that the CAMP inducibility of the phosphoenolpyruvate 
carboxykinase promoter is mediated through a region of CEBPa's tram-activational 
domain lying within its first 124 amino acids. Furthermore, it appears that the region of 
CEBPa's trans-activation domain which mediates CAMP inducibility is distinct h m  the 
regions of its sequence which mediate biding to TBP and TFlIB and its influence upon 
basal transcription. These facts suggest the possible intervention of a co-activator or 
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linking factor with C/EBPa, or perhaps interaction with other members of the pol [I pre- 
initiation complex to mediate CAMP inducibility of transcription. 
Some brief mention of the unique trans-activational domains of C/EBPa's hepatic 
counterpart C/EBPP is also in order, as it plays a role in the context of this thesis as well. 
Initial work by Descombes and Schibler, (1991), locdized the CEBPP Pam-activation 
domain to the first 13 1 amino acids of the protein. This work was supported by the 
findings of Trautwein, et al. (1995), who demonstrated that the tram-activational 
capabilities of C/EBPP were located within an acidic region of its sequence, spanning 
amino acid residues 2 1 through 105. A sub-region of this acidic domain, spanning amino 
acids 85 to 95, and which possessed hydrophobic character, was suggested to be the region 
capable of making contacts with the basal transcription machinery. The work of Williams, 
et al. (1995), expanded firrther upon the details known of CIEBPP's tram-activation 
domains. These investigators described two negative regulatory regions in the C/EBPP 
primary sequence, RD1 and RD2. RD2 was shown to have cell-specific inhibitory 
properties, whereas R D  1 was seen to be cell-type independent in its inhibitory properties. 
The presence of these inhibitory domains suggested the requirement for an activation step 
before C/EBPP would be available for tram-activation. Potentially this activation step 
could arise fiom covalent modification of the negative regulatory domains, the nature of 
the modification either occurring ubiquitously or being cell-type specific depending upon 
the domain. Furthermore, these researchers were able to subdivide the activation domain 
of C/EBPP into three distinct regions or activation domain modules ( ADM's). ADM's 2 
and 3 were found to be highly conserved amongst C/EBP family members, and ADM3 was 
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found to share homology to a fos/jun sequence known as homology box 2 or HOB2 
(Sutherland, et al. 1992). Each activation module was separated by a spacer region of 
variable length and sequence (S 1 and S2). It was observed that independently each ADM 
had low tram-activation capability, however, in combination the three ADM's were able 
to synergize to provide the full tram-activational potential of the transcription factor. 
Refer to Figure 2.6 for schematics of the various tram-activation, dimerization and 
DNA-binding domains of C E B P a  and 9. 
23.13 Multiple Translation Products of C/EBPa and P 
Both CtEBPa and P have multiple translation products which are translated h m  
a single mRNA species by initiating at different AUGs within the same reading h e .  It 
should be stressed that neither of these C/EBP isoforms are understood to undergo 
differential splicing to produce these translation forms, in fact both genes are intronless. 
Presumably, multiple translational species can arise from the leaky ribosomal scanning 
mechanism outlined by Kozak (1989). The phenomenon of multiple CEBP isoform 
translation products from a single mRNA was first described for C/EBPP by Descombes 
and Schibler, (1 99 1). Two translational forms of C/EBPP were described, a 39 kDa form, 
LAP or liver activator protein; and a 20 kDa form, LIP or liver inhibitory protein. These 
two translation fonns share the C-terminal145 amino acids containing the basic region and 
leucine zipper motifs, but LIP lacks a tram-activation domain. Thus LIP is capable of 
Figure 2.6 Schematic diagram of  the tram-activation, dimerization and DNA-binding 
domains of CEBPa and C/EBPB. The abbreviations used are: AD, activation domain; 
bZIP, basic region - leucine zipper; TE, tram-activation element; RD, repressor 
domain; S 1 and S2, spacer regions. Numbering corresponds to the amino acid residue 
of the primary sequence at which a domain begins or ends. 
forming homo- or hetero-dimers and thereafter capable of binding DNA, but cannot tram- 
activate a gene promoter. Due to the potential of formation of LAPLIP heterodimers, 
these workers proposed a model in which LP, upon forming a hetero-dimer with LAP, 
would inhibit its tram-activational capability stoichiometrically. Therefore, the relative 
ratio of LAP/LIP within the cell could determine the overall ham-activational activity of 
CEBPP. 
Similarly, two different translational forms of C/EBPa have also been reported 
(Ossipow, et al. 1993 and Calkhoven, et al. 1994). These two translational forms 
correspond to the polypeptides C/EBP-42 and CEBP-30 which differ in their N-tennini. 
Much like LAP and LIP, C/EBP-42 is a full length C/EBPu possessing full Ram- 
activational capability, whereas C/EBP-30 lacks a tram-activation domain, and is capable 
of forming transcriptionally inactive heterodimers with full length CEBPa. 
Recently, Lincoln, et al. (1 998), have presented work challenging the physiological 
significance of truncated forms of CEBP proteins, suggesting that these smaller 
polypeptide species are merely proteolytic degradation products. It should be noted 
however, that the results of a number of other groups utilizing similar protein lysate 
preparation conditions suggest that these truncated polypeptides are indeed physiologically 
significant, and can in fact be influenced by a number of different physiological stimuli, 
including hormones (Hemati, et al. 19%). The multiple translation product phenomenon 
of CEBP proteins will be further considered within Section 4 of this thesis. 
Mention must also be made of a unique, ubiquitously expressed CEBP isofonn 
known as CIEBPI;. CIEBPG is expressed to some degree in all tissues so far examined, and 
its expression is induced by DNA damage. C/EBP& is also known as CEBP homologous 
protein (CHOP- 1 0)  (Ron and Habener, et ai. 1992) or GADD 1 53 (Growth and DNA 
damage-inducible gene) (Fornice, et al. 1989). The CEBPC; gene spans five kilobases, and 
unlike most C/EBP isoforms, has four exons. The CIEBPL; protein possesses a leucine 
zipper and basic region but lacks a tram-activation domain. C/EBPC; is capable of forming 
transcriptionally inactive heterodimers with other CEBP isoforms, but unlike truncated 
protein f o m  of C/EBPa or P, cannot actually bind DNA due to an aberration in its basic 
region which precludes the formation of a functional DNA-binding domain. Thus, CEBPL; 
can also act as an endogenous dominant negative inhibitor of C/EBP isoform activity, but 
in a manner which completely chelates the heterodimer away h m  DNA. It should be 
noted that CIEBPI; is likely not expressed in most cells to any great extent under normal 
growth conditions. The results of Ron and Habener, (1992), and Fornice, et ai. (1989), 
suggest that CEBPC; expression may be limited to the GO stage of the ceH cycle. 
A similar inhibitory CEBP isoform, C/EBPy (Roman, et al. 1990; Thomassin, et 
al. 1992 and Cooper, et al. 1995), is also thought to be ubiquitously expressed, but its 
main role appears to be the dominant negative regulation of CEBP isoform function in 
undifferentiated, non-proli ferating cells. 
23.2 Tissue-Specific Expression Patterns of C/EBPa and P 
The tissue-specific expression of C/EBPa was first described in mouse 
(Birkenmeier, et al. 1989). Considerable levels of C/EBPa mRNA were observed in liver, 
fat, intestine, lung, adrenal gland, and placenta. These workers also recognized that 
C/EBPa expression was limited to fully differentiated liver and fat cells, and that in liver 
and intestine, expression became observable only slightly prior to birth. In humans, 
CfEBPa was found to be expressed at its highest levels in placenta, although it was also 
detectable in liver, lung, skeletal muscle, pancreas, small intestine, colon and leukocytes 
(Antonson, er al. 1995). 
Prior to the beginning of the work this thesis describes, a few reports had surfaced 
regarding the hormonal regulation of expression of CEBP isoforms in adipose tissue, 
along with a single report concerning regulation in an intestinal cell line. Glucocorticoids 
were observed to have a negative effeet upon C/EBPa expression in firlly differentiated 
3T3-L1 adipocytes and in white adipose tissue (MacDougald, et al. 1994). As will be 
discussed in Section 4 of this document, and as will be revealed shortly based upon the 
work of another group, the effect of glucocorticoids upon C/EBPa in adipose tissue is 
distinct fiom that of which occurs in liver. Similarly, insulin also down-regulates CIEBPa 
expression within the fully differentiated 3T3-L1 adipocyte (MacDougald, et al. 1995). 
Potentially also of interest, the known insulin-sensitizing agents, the thiazolidinediones 
(Forman, et al. 1995 and Lehmann, et al. 1995) have the completely opposite effect upon 
C/EBPa expression in the 3T3-L1 adipocyte, inducing both accumulation of mRNA and 
protein (Hemati, et al. 1998). The only known report of hormonal regulation of C/EBPa 
in intestinal cells described the inductive effects of serum upon the transcription factor's 
expression within rat intestinal epithelial EC-6 crypt cells (Boudreau, et al. 19%). Other 
than the known inhibitory effect upon C/EBPa expression during the acute-phase response 
in liver (Alam, ef al. 1992), little has been previously reported of hepatic C/EBPa 
regulation other than a single report by Ramos, et al- (1996), which presented findings 
demonstrating that the steroid-induced fell cycle arrest of rat hepatoma cells required a 
glucocorticoid mediated induction of C/EBPa. No other information regarding the 
hormonal regulation of CEBPa expression in liver had arisen, thus providing a need for 
the idormation which will be presented in Section 4 of this thesis. 
A fmal concept concerning the regulation of CEBPa expression is that the gene 
for CEBPa is auto-regulated by its own gene product. The first evidence of C/EBP auto- 
regulation was identified in the mouse C/EBP promoter by Christy, et ui. (1991), and 
confirmed by Legraverend, et al. (1993). These investigators characterized a number of 
the CEBP promoter's cis-elements, including a potential CEBP binding site which could 
form heat-stable complexes with liver-enriched proteins in v i m  These liver-enriched 
factors were recognized by C/EBPa specific antibodies. Further, evidence in support of 
CEBP auto-regulation was identified in the human C/EBPa promoter (Timchenko, et al. 
1995). Although sharing a high degree of sequence similarity with the mouse CEBP 
promoter, the human promoter displays a unique mechanism of auto-regulation. No known 
C/EBP binding cis-element occurs in the human promoter, rather auto-regdation occurs 
via the induction of the DNA-binding activity of an ubiquitous factor known as the 
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upstream stirnulatory factor (USF) in response to the a-isoform of  C/EBP only. 
The cloning, and expression profile of C/EBPP was reported by independent groups 
in 1990, and in three different species. The rat isoform of C/EBPP was initially found to 
be expressed in liver, lung, spleen, kidney, brain and testes; however, significant protein 
levels were observed only in liver (Descombes, et al. 1990). This was the first indication 
that post-transcriptional regulation might play an important role in CEBPP expression. 
The rat isoform of C/EBPQ was independently discovered by Poli, et al. (1 990) and was 
named IL6-DBP by this group. IL6-DBP was defined as a hepatoma enriched protein 
sharing strong homology to CEBP in its leucine zipper and basic region domains, and also 
characterized by its ability to bind to interleukin-6 (IL-6) responsive elements of a number 
of acute-phase genes. The human form of C/EBPP was isolated based upon its ability to 
bind to the IL- 1 response cis-element of the IL-6 gene promoter (Akira, et al. 1990). This 
human form of ClEBPP was termed NF-IL6 or nuclear factor for interleukind expression. 
Like IL6-DBP, NF-IL6 was seen to be induced by IL-6, as well as IL-1 and LPS, and could 
bind to the promoters and affect the expression of a number of genes involved in the acute- 
phase response, inflammation and hemopoiesis. The mouse form of C/EBPp, AGPEBP 
was defined as a CEBP-like transcription factor which could bind to and effect the 
transcription of the a, -acid glycoprotein gene (AGP) (Chang, et al. 1 990). 
Some information regarding the effects of insulin and glucocorticoids upon CEBP 
p expression in adipose tissue and intestine has surfaced during the course of this thesis 
work. In opposition to its effects upon C/EBPa within adipose tissue, insulin has a strong 
inductive effect upon C/EBPP expression (MacDougald, et al. 1995). This comlates to 
some degree to the effects of insulin upon CEBPP in liver, which will be presented in 
Section 4 of this work. Interestingly, in rat intestinal epithelial crypt cells, serum and 
glucocorticoids both have inductive effects upon C/EBPP expression (Boudreau, et af. 
1996). Little information regarding the regulation of C/EBPP expression in liver has been 
reported, therefore one objective of this thesis was to present further information on this 
area. A report by Bosch, et al. (1995), suggested that C/EBPP expression is down- 
regulated by insulin both in vitro and in vivo. It also appears that hepatic CEBPf3 
expression may be modulated via a more ubiquitously expressed transcription factor, the 
CAMP response element binding protein (CREB) (Niehof, et al. 1997). Potentially, 
induction of CIEBPP expression via mediation by CREB could allow the influence of 
cellular signals acting through protein kinase A (and thus CAMP). The role of CAMP in 
the regulation of C/EBPP expression within liver will be discussed in Section 4. 
233 Biological Roles of C/EBP Isoforms 
CCAAT/Enhancer-Binding protein isoforms are a group of related proteins widely 
involved in tissue differentiation, metabolic regulation and immunity (for minireview see 
Lekstrom-Himes and Xanthopoulos, 1998). The purpose of this section is to provide an 
overview of some of the biological processes in which CEBP isoforms are required, 
specifically dealing with the a and f3 isoforms of C/EBP, which are of relevance to this 
thesis. This overview will begin with a survey of the knowledge attained fiom in vivo 
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knockout models of C/EBPa and P, followed by a more in depth consideration of the roles 
of C/EBPa and f3 in biological processes occurring in adipose tissue, and most relevant to 
this particular work, in liver. 
2.3.3.1 In Cr ib  Knock-Out of C/EBP Isoforms 
Homozygous deletion of the debpa gene in the mouse was first reported by Wang, 
et al. (3995). The most obvious phenotypic alteration in these C/EBPa knock-out mice 
was that they succumbed within 8 hours after birth due to hypoglycemia More detailed 
analysis of these animals showed that they had no hepatic glycogen stores and that the 
mRNA levels of glycogen synthase were reduced. Furthennore, the developmental onset 
of expression of the two main gluconeogenic genes, PEPCK-C and glucose-6-phosphatase, 
was delayed and offered a potential explanation for the severe hypoglycemia Levels of 
both these enzymes rose back to near control levels over time; however, this required the 
mice to be sustained via glucose gavage. It is possible that some related CEBP family 
member might have been compensating for the loss of ClEBPa in the time period after 
birth, however the fact that these neonates had to be sustained by glucose gavage 
confounds matters, as both PEPCK-C and glucose-6-phosphatase are potentially regulated 
by glucose, albeit reciprocally (see section 2.2.4). There was also no accumulation of  lipid 
in the hepatocytes and adipocytes of these animals, and expression of brown adipose tissue 
uncoupling protein was reduced. Thus, it would appear h m  this study that C/EBPa is 
absolutely required for the maintenance of metabolic fuel levels in the neonate, having 
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profound effects on the normal metabolism of both adipose and liver tissues (reviewed by 
Darlington, et al. 1995). CEBPa deficient mice were also observed to have defects in 
their regulation of hepatic growth and lung development (Flodby, et 02. 1996). The cellular 
architecture of  both hepatocytes and pneumocytes was seen to be perturbed, with liver 
showing a phenotype similar to a regenerative state, and lung demonstrating abnormal 
dveolar structure. Hepatocytes were also observed to possesses significantly increased 
levels of c-myc and c-jun mRNAs, indicative of active proliferation, as was the observed 
increase in levels of proliferating cell nuclear antigedcyclin. In addition to the essential 
role in maintenance of metabolic homeostasis outlined by the earlier work of Wang, et al. 
(1 999,  this study also demonstrated a role for CEBPa in the acquisition of the terminally 
differentiated state by the hepatocyte. The C/EBPa gene has also been disrupted 
specifically within the adult mouse liver (Lee, et aL 19971, via a CreAoxP-mediated DNA 
recombination system (Sauer, 1993). The resultant phenotype of hepatic CEBPa 
dis~ption in the adult again showed decreases in expression of PEPCK-C and glycogen 
synthase, as a well as inhibition of bilirubin UDP-glucuronosyltransferase expression 
required for proper bilirubin detoxification. As a result these mice became severely 
jaundiced. The inhibition of PEPCK-C expression in the adult CEBPa knock-out mouse 
demonstrates the inability of other CIEBP isofoms to compensate for loss of C/EBPa in 
the adult, a notable developmental difference from the neonatal knock-out model presented 
by Wang, et a/. (1995). 
In contrast to CEBPa disruption, the majority of the phenotypic effects due to the 
targeted disruption of the CEBPf3 gene appear to be centred upon the immune system 
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(Tanaka, et al. 1995). C/EBPP deficient mice are extremely susceptible to infection, 
having impaired macrophage activity. It should be noted, however, that a small subset of 
C/EBPP deficient mice demonstrate reduced levels of PEPCK-C expression and a certain 
percentage of perinatal lethalities, suggesting that C/EBPQ may also play some role in 
gluconeogenic regulation in the neonate (Cmniger, et al. 1997). 
233.2 Role of C/EBP Isoforms in the Biology of the Adipocyte 
CCAAT/Enhancer-Binding protein isofoms are known to be involved in the 
differentiation process which converts pre-adipocytes into fat storing adipocytes, as welt 
as being involved in the regulation of genes critical for fat metabolism in the tirlly 
differentiated adipocyte (for reviews see MacDougald, et al. 1995b; Mandrup, et a/. 1997 
and Darlington, et aI. 1 998). Some of the first evidence regarding the role of CIEBPa in 
adipocyte differentiation and the trans-activation of adipocyte specific genes was presented 
by Christy, et al. ( 1989). This work demonstrated an upregulation of C/EBPa expression 
in the 3T3-L1 pre-adipocyte during differentiation, as well as the ability of this 
transcription factor to tram-activate the promoters of several differentation-induced genes, 
including the adipocyte-specific fatty acid binding protein 422(aP2) and stearoyl-CoA 
desaturase 1 (SCDI ). The work of Cao, et at. (199I), showed that the expression of 
CEBPa was upregulated relatively late within the differentiation process, whereas two 
other C/EBP isoforms, CEBPP and CEBPS, were observed to be expressed early on in 
the differentiation process, and were in fact induced by adipogenic hormones. Expression 
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of both C/EBPp and C/EBPG was seen to drop dramatically just before the induction of 
C/EBPa later on in the differentiation process. These observations were further supported 
by the findings of Yeh, et al. ( 1 999, who were able to define the individual patterns of 
CEBPP or C/EBPG induction by specific adipogenic hormones. These workers were able 
to demonstrate that these two C/EBP isofoms were responsible for relaying certain 
adipogenic hormonal signals, ultimately resdting in the activation of CEBPa, which is 
required for the tram-activation of adipose-specific genes involved in uptake, synthesis, 
and storage of fatty acids. Of importance to this thesis, two separate groups were able to 
demonstrate the absolute requirement for C/EBPa in the differentiation and metabolism 
of the adipocyte, by utilizing antisense construct methodology (Sarnuelsson, et al. 199 1 and 
Lin and Lane, 1992). Both groups were able to demonstrate that expression of specific 
C/EBPa antisense constructs could block expression of both CEBPa mRNA and protein, 
resulting in the inhibition of a number of adipocyte-specific genes and an inability of the 
fat cell to accumulate criacylglycerides. 
Not surprisingly, CEBPa is also known to tram-activate a number of adipocyte- 
specific genes involved in glucose metabolism and global energy homeostasis. For 
example, C/EBPa is thought to be involved in the tissue-specific and metabolic regulation 
of the insulin-responsive glucose transporter (GLUT4) (Kaestner, et al. 1990). The a- 
isoform of CEBP is also thought to be an important regulator of leptin, the obese gene 
product (He, er al. 1995; Hwang, et al. 1996 and Hollenberg, el ai. 1997). An additional 
level of complexity has been observed, concerning the ability of C/EBPa and C/EBPS to 
tram-activate the promoter for the y, isoform of the peroxisome proliferator activated 
receptor (PPAR y.J (Clarke, et al. 1997), a form of nuclear receptor involved in regulating 
adipogenesis and lipid metabolism. As is the case for CEBPa, PPAR y2 is also involved 
in trum-activating the leptin gene. 
Thus, C/EBP isoforms are deeply entwined in the regulatory mechanisms of 
adipocyte differentiation and metabolism, serving at multiple levels of regulation and at 
various control points in order to insure the appropriate development and maintenance of 
the biological profile of the adipocyte. 
2.3.33 Role of CIEBP Isoforms in the Biology of the Hepatocyte 
Within the liver cell, CEBP isofoms appear to play a part not only in the trans- 
activation of a number of metabolically vital genes, but also hold important roles in 
immunity, liver cell proliferation, and regeneration. 
In the case of regulation of inflammatory and immunity fbnctions (for minireview 
see Poli, 1998), C/EBPa does not seem to play a major role. In fact, in response to 
inflammatory stimuli, C/EBPa expression is down-regulated with a subsequent 
upregulation of the f3 and 6 isoforms of CEBP (Alam, et d. 1992). Both CIEBPP and 
C/EBP6 are capable of tram-activating the promoters of various genes involved in 
immunity, including the cytokines [LA, IL- 1 P, tumor necrosis factor - a (TNFa), IL-8 and 
IL- 1 2 (Akira, et al. 1 990; Wedel, et af. 1996; Pope, 1994 and Shirakawa, et ol. 1993), and 
various genes involved in cell mediated immunity such as nitric oxide synthase 
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(Lowenstein, et al. 1993), lysozyme (Goethe, et ul. 1994) and granulocyte colony- 
stimulating factor (Dunn, et al. 1994). 
The concept that C E B P a  played an antiproliferative role in differentiated cell types 
was first suggested by Umek, et al. (1991). This idea was confirmed in the liver cell by 
Mischoulon, et al. (1 992), who were able to demonstrate a decrease in C/EBPa mRNA 
levels correlated with the regenerative response of the cells after a partial hepatectomy. 
Further work revealed that not only the expression of C/EBPa, but also its DNA-binding 
activity, was down-regulated in the regenerating liver (Rana, et al. 1995). In contrast, the 
DNA-binding ability of the p-isofom of CEBP was seen to increase under proliferative 
conditions, although no change in its overall expression was witnessed. These concepts 
were supported by the work of Diehl, et al. (1 996), which showed that in a rat hepatocyte 
cell line, which normally expressed minimal amounts of CEBPa, adenoviral-mediated 
overexpression of this same factor had a dominant anti proliferative effect. 
Much Like in adipose, CEBP isoforms are involved in the tram-activation of a 
considerable number of metabolically relevant genes in the hepatocyte, including acetyl- 
CoA carboxylase (Tae, et al. 1995), serum albumin (Friedman, et al. 1989), insulin 
responsive GLUT-4 (Kaestner, ef al. 1990) and most importantly for the purposes of this 
thesis, PEPCK-C (for review see Croniger, et al. 1998). 
CIEBP isoforrns are known to bind to multiple sites of the rat PEPCK-C promoter, 
and assist in the mediation, and potential cross-talk between a variety of hormonal 
responses (see section 2.2.3.1). Given that individual C/EBP isoforms have unique 
expression patterns and responses to honnonal regulation in liver (as will be revealed in 
section 4), and can potentially heterodirnerize as well, the identity of C/EBP isofonns 
absolutely required for individual hormonal responses of the PEPCK-C promoter is of 
great interest. Along with characterization of the hormonal regulation of the two main 
hepatic CEBP isoforms, C/EBPa and CEBPP, the other primary aim of this work is to 
assess the CEBP isofom requirements in mediation of several PEPCK-C promoter 
hormonal responses, including those of glucagon (via CAMP) and glucocorticoids. 
2.4 Approaches for Inhibition of CfEBP Isofom Activity or Expression 
Two of the most widely utilized methods for inhibiting the activity of a given 
cellular factor are the use of the dominant negative inhibitor to interfere with the factor at 
the level of its biochemical activity, and the use of antisense constructs to inhibit the 
expression of the factor within the intact cell. 
2.4.1 GBF-F, a Dominant Negative Inhibitor of C/EBP Isofonn Activity 
The concept behind producing a dominant-negative molecule to inhibit C/EBP 
isoform function arose due to the development of an inter-helical salt bridge rule to 
describe the specificity of dimerization between two helices of a potential leucine zipper 
(Vinson, el ai. 1993). The inter-helical salt bridge rule is based upon the known 
dirnerization specificities, in terms of electrostatic interactions, of a number of bZIP family 
members. These guidelines allow for considerable success in the prediction of potential 
heterodimerization partners based upon the identity of amino acids at given positions of  
the amphipathic helix. Using this d e ,  it is possible to design specific polypeptides 
capable of heterodimerizing with a specific bZIP-containing monomer. The manufacture 
of these polypeptides could potentially result in the production of a dominant-negative 
molecule if the designed polypetide lacks a tram-activation domain, or in some manner 
interferes with the formation of  a proper "Scissors-Grip" necessary for DNA-protein 
interaction. 
A chimeric dominant-negative molecule to CEBP isoforms has been created 
utilizing the inter-helical salt bridge guidelines (Olive, et al. 1996). This molecule known 
as GBF-F, consists of the DNA binding - basic region of the plant bZIP protein GBF-I 
(Giuliano, et al. 1988 and Schindler, et al. 1992) fused to an engineered leucine zipper 
known as the "F" zipper (Vinson, et al. 1993). The "F" zipper preferentially forms 
heterodimers with CEBP isoforms due to specific amino acid substitutions made at 
positions e and g of the zipper amphipathic helix. Thus the GBF-F molecule, by 
preferentially forming heterodimers with CEBP fami 1 y members, inhibits C/EBP trans- 
activation due to the inability of the GBF basic region to recognize the dyad symmetrical 
CEBP consensus cis-element. It should be noted that GBF-F may potentially form trans- 
activationally inactive heterodimers with fos and jun monomers (C.R. Vinson, personal 
communication to W.J. Roesler). The dominant-negative nature of GBF-F over CEBP 
isoforms makes it an excellent tool for ascertaining the overall necessity of C/EBP 
isofoms in the transcriptional responsiveness of a given gene. The GBF-F molecule has 
been utilized in a portion of  this thesis work to determine the need for CEBP isoforms in 
the hormonal responses of the rat PEPCK-C promoter. Obviously, GBF-F cannot 
distinguish between individual C/EBP family members, due to the similarity of the leucine 
zippers among isofonns. The following section (2.4.2) will address the use of specific 
antisense constructs to inhibit either C/EBPa or C/EBPP expression within the intact cell. 
2.4.2 The Utilization of Antisense RNA Constructs to Inhibit Gene Expression 
Antisense RNAs interfere with gene expression by hybridizing to target RNA, 
rendering it fimctionally inactive, the target RNA being the complimentary sense mRNA 
of the gene of interest (for reviews see Takayoma, et al. 1988; van der Krol, et al. 1988; 
Wagner, 1995 and Branch, 1998). The manner in which an antisense molecule inhibits the 
expression of a given gene can be varied, but in any event its purpose is to ultimately 
inhibit the translation of the target mRNA after formation of a sense-antisense hybrid 
RNA. The formation of this duplex hybrid may render it more susceptible to double 
strand-specific nucleases, or may potentially interfere with post-transcriptional processing 
of the sense transcript. 
Antisense molecules have been utilized to inhibit the expression of a variety of 
eukaryotic genes, including as examples, thymidine kinase (Izant, et al. 1984 and Kim and 
Wold, 1985), the c-myc proto-oncogene (Yokoyarna and Imamoto, l987), c-fos (Ledwith, 
et uZ. 1 990), growth hormone (Paulssen, et al. 1990) and the glucocorticoid receptor (Pepin 
and Barden, 1991). As mentioned in section 2.3.3.2, two groups have utilized CIEBP 
antisense constructs to assess its roles in adipocyte differentiation and adipocyte specific 
gene expression. The construct utilized by Sarnuelsson, et al. (1991), in 3T3-F442A pre- 
adipocytes corresponded to MI-length C/EBPa and produced a 62% decrease in C/EBPa 
mRNA levels, whereas the construct utilized by Lin and Lane (1992), corresponded to an 
approximately 400 bp segment complementary to the coding region of the C E B P a  trans- 
activation domain. Lin and Lane's antisense RNA, perhaps because of its smaller size, 
produced a much more effective 9598% reduction in CEBPa mRNA levels, and 
essentially aboiished CEBP protein levels within the stable transfected 3T3-L1 pre- 
adipocyte. The work presented in this thesis has utilized C/EBP antisense constructs 
similar to those utilized by Lin and Lane (1992). These antisense constructs, specific for 
either C/EBPa or C/EBPQ, are complimentary sequences corresponding to regions of either 
protein's trans-activation domain. The sequences utilized are specific for each individual 
isoform, and thus show specificity of targeting for the intended isoform. 
Clearly, the use of antisense methodology is a powerfid tool in the characterization 
of the roles of specific gene products within the intact cell as long as special attention is 
payed to the uniqueness of the sequences utilized, as well as to their size relative to the full 
length transcript. 
2.5 Objectives 
The objectives of this thesis are two-fold and are based upon the inadequacy of the 
current literature to define the hormonal regulation profiles of CEBP isoforms in the liver, 
as well as the need to identify the specific CEBP isoforms which participate in the 
complex hormonal responses of the endogenous gene for PEPCK-C in the hepatocyte. 
As presented in section 2.3.2, a significant amount of information has arisen 
concerning the hormonal regulation of C/EBP isoforms in metabolically relevant tissues 
such as adigose and intestine. However, information regarding the patterns of hormonal 
regulation within the hepatocyte are lacking. As this literature review has attempted to 
demonstrate, CEBP isoforms are vital for the expression and regulation of many 
metabolically vital genes, including many which are involved d i i t l y  in glucose 
homeostasis within the liver. As many levels of regulation are required in the complex 
milieu of metabolic processes, it should not be surprising that a higher order of hormonal 
control over actual gene regulatory factors should occur, and that these regulatory 
mechanisms shouid be uniquely tailored to the specific tissue in which they operate. 
The gene promoter for PEPCK-C is an excellent model for the study of hormonal 
regulation of gene expression, given its multiple integrated responses to hormones, and the 
complex organization of its promoter architecture. A considerable amount of work has 
been done towards understanding the mechanisms of hormonal regulation of hepatic 
PEPCK-C expression. However, much of this work regarding the roles of CEBP isoforms 
has been based upon synthetic or artificial systems, and although providing an excellent 
framework for understanding, cannot by its nature truly reflect the mechanisms which 
operate in the intact cell upon the endogenous gene promoter. Given that individual 
CIEBP isoforms have unique patterns of expression, and hormonal regulation within the 
liver, along with their inherent ability to form heterodimers which can produce multiple 
forms of uniquely regulated trans-acting factors, the need to ascertain the exact 
requirements for specific C/EBP isoforms in mediation of these hormonal response 
mechanisms should be obvious. 
Given these above considerations, the specific objectives of this thesis are: 
(1) To define the patterns of regulation of various hormones over the expression 
of the two main liver C/EBP isoforms, C/EBPa and CIEBPP, within rat 
hepatoma cells, as well as some characterization in vivo, in adult rat liver. 
(2) To define and characterize which specific CEBP isoforms mediate the various 
hormone responses of the rat PEPCK-C promoter in liver. CEBP isoform 
requirements will be characterized by the production and analysis of a 
number of rat hepatoma H4IIE stable cell lines expressing the dominant- 
negative inhibitor GBF-F, or constructs designed to produce specific 
C E B P a  or C/EBPQ antisense WAS.  
3. MATERIALS GND METHODS 
3.1 Reagents 
All reagents used were of molecular biology or analytical grade as appropriate. The 
names of the reagents utilized and the name of their supplier are listed in Table 3.1. The 
addresses of the individual bio-molecular supply companies from which reagents we= 
obtained are listed in Table 3.2. 
Table 3.1 A List of Reagents Utilized 
I Acrylamide Bio-Rad 
1.-----..-.---.. ---.-..--..--......-..--~~.~~~~~~~~....~-.*~~~.-..........~-.--.------------.----*-...~**--.....-.-~.---.------------...-----.4-....~~~..-..~~.~.....~...-..-.~~.-...-..~, 
i Agarose Bio-Rad 
~--...------.-.-.-.----....-......----...---.-.--.--.-..-.....-.-----.-----.------.--------------.--..--.-----.---....-.-.--.--------...-----a..--....---...-.-.*-.-.......-..-...--...-i 
i Ammonium Persulphate 'i Bio-Rad 
!-....- ........................................................................................................................................................... 
i Bovine Serum Albumin i ICN 
I Bromophenol Blue i Sigma 
/ Coomassiea Brilliant Blue Stain Sigma 
.......................................................................................................................................................................................... 
! Calcium Chloride (CaC13 ! BDH 
j Diethylpymcarbonate (DEPC) j BDH 
........................................ L.... ...--.........-..-.--.....+--..-...-..-.----.---.-.-.--------*..--...-.--.-...~~~..- ~- --- -----* -*-*-*...~.~.-....-~...-.-. a- ; 
Dimethylsulfoxide @MSO) i Sigma 
p. . ............................................*....*...................4..................... ! 
I BDH i Formamide 
-.---*.*......---......-*..-..-..-....-.-..--*.-.---*-----.--.-.-...--4-..---.....--...----..*-..-.--....-...---. ........................................................................ ! 
! Glacial Acetic Acid ! BDH 
?........... ................................................-..................................................-............................. a.-.-..--.*-.-...-..-.a 
! BDH Glycine 
L.... ........................................................................................................................................ .......................................... I 
USB N-2-Hydroxyethylpipe&ne-N'-2-Ethane Sulfonic Acid 
(HEPES) 
... ........... '."---.. ---. .................................................................................................................*.......................................... ! 
i BDH i Isobutanol 
1. ...."-..~~.~.-..~....-~-.-..~*...~-...~~.-....~~~~.~~~~.~~.-----.---------..*-..~.......~~.~.-.....~...~~.~~~-.~.*-.~--~-~.~..----..-..-.~.*....---....--.--.-.*---...~.......~~.-...~f 
LMP (low melting-point) - Agarose i Bio-Rad 
...-----**-...*.--....-.......-~...~.*.~..~~~.-~~~~**..~~--~-.*.~-~..~-......~....~.....~.~.-...~~~~~~~**--.~.-.~~-.~~*...-~..~~~....-......-.*...-...**...*.~.~.-.~........~~~~~~~....~. i 
Magnesium Chloride (MgC13 / BDH 
(.*-----...- "..... ..................................................................................*........................................~.........................................., 
i 2-Mercaptoethanol(2-ME) i Sigma 
L...... ...................................................................................................................................... a-.*.*-.---**-........*..*.a 
! Methanol BDH 
N,N'-Methylene-Bis-Acrylarnide I Bio-Rad 
:"-.-"...-".........'-'.  ...............................................................................................................*.......................................... ! 
i (3 -m-Morpholino]propanesulfonic acid) MOPS I Sigma 
)- ............................................................................................................................................ 4-.-.*-.-.-.*.-.*-a 
j BDH Nonidet NP40 
! Polyethylene glycol 8000 (PEG 8000) .i BDH 
~....--...--...--.-...-.--.-*-.-.---*.--~.~.*--.*-.-....-~...........~.-.....--....--~..-....-..-------------*-..-.--.-.-------.....-..------.+..-.--~.-..---------..-----...-...-.....--* 
i Sephadexm G-50 - Fine DNA Grade / Pharmacia 
:- -..---.-------.*..--...-..--.-...-..-..~..~~~~-~~~~~~~.....-.-.~....--..~~.-~~~~~....-~~..~.~---.---~.-----.~..~~~-..--....--..-.~~~......-~~~~~.....-.**..*.**.~.-------.-------.---- ! 
Sodium Acetate 'i BDH :..--...-..-....-.-..... . ............................................................................................................. 4..-*-...--....-.-.----*--.--..--.--.-.--.* ! 
f Sodium Bicarbonate (NaHCO,) i Fischer 
,.~..............~..~....~..~~~*.~*~*......*..**~.~..*.*~~~~.~~~~~..~~~....~...~~~~~~~~.~~~~~~.~~~~~*~~.~..~.*~~~~~~~..~.~~~~~~....~~~~.....~ *----.--..---.--.---------.------.--.------a 
i Sodium Citrate i BDH 
i Spermidine -3 HCl (N-13-Aminopropyl]- 1 ,CButanediamine) i Sigma :----.---..--...-..--...---..--.-.-.----.....*.*..**.*..-*-.........-.----..-......'--.---.--.------.--.------ ? 
i Tris-~ydroxymethy l] Aminomethane (Tris) GIBCO-BRL :-.--..--...-.....-.......-...-.--...-.....-...-....-.......-.----*...--.*..--.*-.-.---.....-*..*.-------.----..-...*-.*.*....*..*.**--...***.*--....-...-.--.---.--..--...-..--...-.-...# 
I Trypsin-EDTA i GIBCO-BRL 
............................................................................................................................................. ~.--.---* *-*~~-~~-~*-- .-..*- .*-. .. .-..* 
Sigma f Tween-20 
L-..........-.....--..~.~*-.~~~*.-.~~~-........-...-.-...-.~.~.~~..-.~~~.............~~-.*..~..-.~~-~~~~.----.-----~.-..---......-..~~*-.--..~~~~..**.**..~.-~~**.*..**.*.--*---~..**..*! 
i BDH i Urea 
Yeast Total RNA i Boehringer 
! Mannheim !.---..------.---..--.-.-.~~...**~~.-~~~~-....-..~.~-.~..--.~.~~~~-...~~~...-.-..--.------....-...-------.--------.--.....-.....----.-........,.*..* --*.---------*--*-*-*. -*.- ..-. ---.f 
i Reagents for Bacterial Growth 
ICN f Ampicillin 
L~.~~~... . . . . . .~.. .- . . . . . . . . .~~~.~.~.-.~.. .-~~~~~~~~~~~~~...~~~~.-. . .~~~... . .- .*.*.-~~~~~..---.~-~~-~.~-.--------.----. .- . .- . .--- .---~--. .- .~~... . .*~~~~~~~...- .~.~~~.---. . . .-- .-- .- .- . .~ 
f DIFCO ! Bacto-Agar 



-.__-_._.---_....-~---------...--..-------...-.~~~.~~~~..~~~...~~~~~.~.~~~.~~~~.~.~~~~~.~~...-.--...--~~.~....---~~.~~.-~~~~*-*.*---**--*-*..--**---*----...*.-**.-.*--------.*--.-.-.~-* 
f 2' 3'-Dideoxycytosine 5'-Triphosphate (ddCTP) i Pharmacia 
p.- - - - . - - - . - . - - - . . - - - * - - - - - - * - - - - - * - * - - . . * . *~~. -~~~-- -~~~~-~--~- -~*~~~~-~-*~* . -~-~~-~--~-~~-~* . . - . . * . - .~- . . * . . . * - * .~-~. -* .~-~- . - . . . -~~-~~~~. .~- - . .~- - . . .~ . . . . . .~~.~~~.- . . .~- - . . - . . - . . . .~a 
Phannacia 2' 3'-Dideoxyguanosine 5'-Triphosphate (ddGTP) 
Table 3.2 The Names and Addresses of Reagent Suppliers 
Supplier 
i Boehringer Mannheim 
..................................................... 
! DIFCO 
i GIBCO-BRL 
i ICN 
)...-. .............................................. 
NEN - Mandel 
.--*...-.-.....-.-..---.---..-...----.....-.......-.., 
Address 
British Drug House, Saskatoon, Saskatchewan, Canada 
.................................................................................................................................. i 
Bio-Rad Laboratories, Mississauga, Ontario, Canada 
.................................................................................................................................. 1 
Boehringer Mannheim Canada Ltd., Laval, Quebec, Canada 
..........-..-..-.---.-.-~.--...-..------.*--.-**----*-*-*-.*.*--.*--*-.A 
Connaught Laboratories, Willowdale, Ontario, Canada 
.................................................................................................................................. 4 
DIFCO Laboratories, Detroit, Michigan, USA 
ICN Biomedical Canada Ltd., St. Laurent, Quebec, Canada i 
Mandel Scientific Company, Guelph, Ontario, Canada 
.. .. ............................................................................................................ 
.____.__.*__.._____~..--.....~*~-..~.-~*--.~~~~-~~~.--~-~~~-.*-...---.-..--.--..-.--.--------.....---...*...---.------..-.---.-----.----------.----...---..----..------.....----.-------- 
Pharmacia i Pharmacia LKB Biotechnology Ltd., Baie d'Urfe, Quebec, 
i Santa Cruz i Santa Cruz Biotechnology, Inc., Santa Cnrz, California, 
i Biotechnology i USA 
i Sigma Sigma Chemical Co., St. Louis, Missouri, USA 
3.2 Bacterial Strains and Media Preparation 
A single Escherichia cofi strain, E. cofi NM522, was utilized for all cloning 
manipulations conducted during the course of this thesis work. This NM522 strain has 
been described by Gough and Murray (1 983) and Woodcock, et al. ( 1  989). 
Bacterial cells which were plated were propagated on Luria-Bertani medium (LB) 
plates at 37 "C. LB plates were prepared by combining water, 10 g of bacto-tryptone, 5 
g of bacto-yeast extract, 10 g of NaCl and 15 g of bacto-agar in a volume of 1 L. This 
mixture was autoclaved for 20 min at 15 lb/sq. in. Ampicillin was added into the medium 
at a concentration of 50 pg/mL once it was sufficiently cooled, the plates were then poured. 
Terrific broth (Sambrook, ef of. 1989) was used to propagate bacterial cells in a 
liquid medium at 37 "C. Terrific broth was prepared by combining water, 12 g of bacto- 
tryptone, 24 g of bacto-yeast extract and 4 mL of glycerol in a volume of 900 mL. This 
mixture was autoclaved for 20 min at 15 lb/sq. in. After sufficient cooling, 100 mL of a 
sterile solution containing 0.1 7 M KI-I,PO, and 0.72 M K,HPO, was added aseptically. 
This solution of potassium salts was prepared by combining 2.3 g of KH,PO, and 12.54 
g of K,HPO, per 100 mL of sterile water and autoclaving at 15 lb/sq. in. for 20 rnin. 
3.3 Cell Culture of Rat Hepatoma H4IIE CeUs 
Rat hepatoma H4IIE cells (Reuber, 1 96 1 and Pitot, et af. 1 964) were maintained 
in Dulbecco's Modified Eagle Medium: Nutrient Mixtwe F-12 (Ham) (1 : 1) - with 
glutamine, containing 5% calf serum and 5% fetal bovine serum, at 37 "C and 5% CO,. 
All cell lines were passaged twice a week via trypsinization at a 1:10 dilution. All cell 
lines were maintained on 1 00 mm tissue culture plates. Stable transfected cell lines were 
selected in media containing 400 pg/mL gentamicin sulphate (G418). Atter individual 
clones had been isolated, the selection pressure was reduced and a medium containing 100 
tcg/mL G4 1 8 was utilized. 
Liquid nitrogen cell stocks were prepared by trypsinizing plates and resuspending 
the detached cells in 10 ml of cell media. The resuspended cells were then pelleted by 
centrifbgation at 3000 rpm for 5 min at 4 "C, the supematant removed and the cells 
resuspended in 1 mL of cell stock fieezing media containing fetal bovine serum, calf serum 
and 10 % DMSO. 
3.4 Animal Handling and Experimental Manipulations 
Male Sprague-Dawley rats of approximately 1 50-200 g weight were utilized for two 
sets of experiments which will be further outlined in section 4. Principles of laboratory 
animal care were adhered to and all protocols were approved by the University of 
Saskatchewan Committee on Animal Care and Supply. Animals were allowed to feed on 
Purina rat chow ad libitum and were maintained on a 12 h day-night cycle. 
Animals which were subjected to a CAMP bolus were initially injected with the 
CAMP phosphodiesterase inhibitor theophylline (30 mg per kg body weight) in a sterile 
PBS vehicle. Following this initial injection animals were injected with 8-CPT-CAMP also 
in PBS vehicle at a dose of 30 mg per kg body weight at 30 min intervals over a 90 min 
time period. All control animals received PBS injections at the same time points. 
Following these injections, animals were killed by decapitation and a portion of liver was 
quickly frozen in liquid nitrogen and stored at -80 "C until RNA isolation could take place 
(see. section 3.7). An additional portion of liver was immediately homogenized in radio- 
irnrnuno-precipitation assay (RIPA) buffer for protein lysate preparation (see section 3.13), 
protein lysates were stored at -80 "C until they were analysed. 
Animals were made diabetic by an intra peritoneal injection of streptozotocin (80 
mg per kg body weight) in 100 mM sodium citrate [pH 4.01 and 150 mM NaCl vehicle. 
Control animals were injected with vehicle only. All animals were tested for glucosuria 
after 5 days with 5L Chemstrips, and all streptozotocin-treated animals tested positive and 
displayed weight loss in excess of 20 g. At this point half of the diabetic animals were 
started on daily injections of 5 RI of NPH insulin injected subcutaneously for 5 days and 
were monitored with Chemstrips to insure appropriate insulin replacement. Mer 5 days 
the animals were killed and livers isolated. Untreated diabetic animals were killed by 
decapitation 5 days after testing positive for glucosuria and control animals were also killed 
at this time. A portion of liver was fkeezeclamped in liquid nitrogen and then stored at -80 
"C until total RNA isolation could take place, while another portion of liver was 
immediately homogenized in RIPA buffer for protein lysate preparation. At the time of 
death all untreated diabetic animals presented blood glucose levels in excess of 25 mM. 
3.5 Geneml Molecular Cloning Procedures 
In general, all protocols outlined within this section are at least partially based upon 
those presented in Sarnbrook, et al. (1989). 
3.5.1 The Polymerase Chain Reaction (PCR) 
Polymerase chain reactions were assembled in a 50 pL volume containing filter 
sterile water, IX PCR buffer containing 20 mM Tris-HC1 IpH 8.41 and 50 mM KCI; 400 
pM of each dNTP, a mix of fonvard and reverse PCR primers (20 pmole each), 1.5 mM 
MgCl,, approximately 1 pg of template DNA and finally, approximately 2.5 units of Tag 
DNA polymerase. The PCR reaction was topped off with 20 pL of mineral oil to prevent 
evaporation. Thermocycling occurred in a Perkin Elmer Cetus DNA Thermal Cycler 
utilizing the following program: one denaturing cycle at 94 OC for 3 min followed by 35 
cycles of denaturing at 94 "C for 30 sec, annealing at 55 "C for 30 sec and extension at 72 
"C for 60 sec. These cycles were followed by a 7 min extension at 72 "C. AAer 
thennocycling PCR products were analysed by agamse gel electrophoresis (section 3.5 -2). 
3.5.2 Agarose Gel Electropbomb 
Agarose gel electrophoresis was typically carried out on 1% agarose gels in I X 
TAE buffer. Ethidiurn bromide was added to the agamse solution to a concentration of 0.5 
pg/mL. The running buffer used for agarose gel electrophoresis was 1X TAE, containing 
40 m M  Tris-acetate and 1 mM EDTA IpH 8.01. Enzyme digests or PCR reactions were 
terminated by adding in an appropriate volume of 5X agarose gel sample buffer containing 
50% glycerol, 50 mM EDTA ipH 8.01 and traces of bromophenol blue and xylene cyan01 
FF, and then placing the mixture on ice. Agarose gels were electrophoresed at between 90 
a d  1 10 volts, until the appropriate amount of band resolution had been achieved. 
3.5.3 Gel Fragment Isolation and Ligation Reactions 
After electrophoresis a small section of gel distal to the DNA band of interest was 
excised and filled with molten 0.W low melting-point (LMP)-agarose which was then 
allowed to gel. Following this the gel was again electrophoresed at 90 volts, constant 
voltage, for an appropriate amount of time in order to insure the band of interest had 
entered the LMP-agamse. The band was then excised in the smallest volume of agarose 
possible. The DNA band of interest was then purified away from the LMP-agarose using 
the Geneclean@ protocol as according to the manufacturers instructions. Purified plasmid 
DNA was eluted from the final washed Glassmilk@-DNA pellet into sterile water by 
incubation at 65 "C for 10 min and with frequent vortexing. 
Ligations were generally set up with a 3:7 (v:v) ratio of vector : insert. Ligation 
reactions were prepared in a 20 pL volume, thus 3 pL of purified vector DNA and 7 pL of 
purified insert DNA were added, along with T4 DNA Ligase (1 unit, corresponding to 
approximately 300 cohesiveend ligation units), T4 DNA Ligase buffer containing 50 m M  
Tris-HC1 IpH 7.6],10 mM MgCl,, 1 rnM ATP, 1 m M  DTT and 5% (w/v) PEG-8000; and 
finally sterile water to bring the reaction up to volume. Ligations were allowed to proceed 
at  16 "C overnight and were then terminated by heating at 65 "C for 10 min. 
3.5.4 Preparation of Competent Em coli NM522 and Transformation 
To prepare competent cells, a single colony of E. coli NM522 was used to 
innmulate 50 mL of LB media, which was then allowed to grow at 37 "C overnight with 
shaking. The next morning, 4 mL, of this saturated culture was used to innoculate a 400 
rnL culture of LB medium which was then incubated at 37 "C with shaking until a density 
of growth indicated by an OD, of 0.375 had been reached. Upon reaching this proper 
stage of growth, the culture was aliquoted into pre-chilled sterile tubes and allowed to 
incubate on ice for I0 min. The bacterial cells were then pelleted by centrifbgation at 3000 
rpm for 7 min at 4°C. The supernatant was decanted and the cells resuspended in 10 mL 
of ice-cold CaCI, solution containing 60 mM CaCI,, 15% glycerol and 10 mM PIPES IpH 
7.01. The cells were again pelleted by centrifugation at 3000 rpm for 5 min at 4 OC. The 
supernatant was discarded and the cells resuspended in 10 mL of ice-cold CaCI, solution 
and then incubated on ice for 30 min. After this incubation, cells were centrifirged at 3000 
rpm for 5 min at 4 "C. The supernatant was discarded and the final competent cell pellet 
was resuspended in 2 rnL of ice-cold CaCI, solution. Competent cells were stored in 
aliquots at -80 OC until needed. 
For transformation of competent cells, 10 pL of the appropriate ligation reaction 
(see section 3.5.3) was added to 100 pL of competent NM522 cells in a 12 mL 
polypropylene tube and incubated on ice for at least 30 min. After this incubation, 
transformation was achieved by heat-shocking the cells at 42 "C for 2 min. The heat- 
shocked cells were then plated on LB medium containing 50 ClglmL ampicillin and allowed 
to grow overnight at 37 "C.  Single colonies were picked for small scale plasmid isolations 
and subsequent diagnostic analysis. 
3.5.5 Small Scale Plasmid Isolations 
All plasmids were replicated within E. coli strain NMS22 (see section 3.2). A stab 
of a single bacterial colony was used to innoculate a 5 mL culture of Temfic broth 
containing 100 pg/rnL ampicillin. Cultures were allowed to incubate at 37 "C with shaking 
overnight. The protocol utilized for small scale plasmid isolation is based upon the method 
of Lee and Rasheed (1990). The final pellet containing purified plasmid DNA was 
-65- 
dissolved in 25 pL, of TE buffer. A typical plasmid isolation using this procedure would 
yield approximately 20 to 35 pg of plasmid DNA fiom a 1.5 mL bacterial culture. 
3.5.6 Sequencing of Double-stranded Plrwmid DNA 
The protocol utilized for double-stranded sequencing of plasmid DNA is based 
upon that presented by Akella and Porter (1993), which in tum is based upon the original 
dideoxy-nucleotide sequencing method of Sanger (1 977) . Reactions were terminated by 
the addition of 4 pL of denaturing polyacrylamide gel sample buffer containing 800/0 
formamide, 10 mM EDTA IpH 8.01 and traces of bromophenol blue and xylene cyan01 FF, 
2nd incubating on ice. 
A denaturing 6% polyacrylamide (1 9: 1 acrylamide : N,N7-methylene-bis- 
acrylamide) 8 M urea gel was used for resolving sequencing reactions. The sequencing 
gel was cast in a Kodak IBI sequencing gel apparatus. A shark's-tooth comb was used for 
sample application. Sequencing reactions were denatured by heating at 80 "C for 4 min 
and were then placed on ice; approximately 4 pL of each reaction was applied to the gel 
per lane. The running buffer used for electrophoresis was OSX TBE, containing 45 rnM 
Tris-borate and 1 mM EDTA [pH 8.03. Gels were run at 2000 volts until the appropriate 
amount of resolution was achieved. Sequencing gels were dried in a vacuum gel drier 
before overnight autoradiography at room temperature using Kodak X-OMAT film. 
3.5.7 Large Scale Plrwmid Isolations 
Bacterial cultures for large scale plasmid isolations were inoculated by first 
streaking a Luria-Bertani (LB) plate containing 50 pg/mL ampicillin with culture h m  a 
-80 "C DMSO stock and incubating overnight at 37 "C. A single colony stab fiom this 
streaked plate was used to innocutate a 5 mL culture of terrific broth containing 100 p g / d  
ampicillin, and this culture was allowed to incubate with shaking at 37 "C over the course 
of the day, whereupon in the late afternoon, it was used to imoculate an appropriate 
volume of tem fic broth containing 1 00 pg/ml ampicillin. This large culture was allowed 
to incubate overnight at 37 "C with shaking. The procedure used for large scale plasmid 
isolation is based on the protocol presented in Sambrook, et a/. (1 989). The purified 
plasmid DNA was dissolved in an appropriate volume of TE buffer ipH 8.01. Plasmid 
DNA preparations were quantified by acquiring the optical density of a given sample at 
260 nm, where an OD, = 1.0 corresponds to 50 pg of pure plasmid DNA. The 04, of 
each sample was also taken, a ratio of OD,JOD,, = 1.7 to 1.8 indicated a relatively pure 
plasmid preparation. Large scale plasmid preparations were stored at -20 "C until needed. 
3.6 Cloning Strategies 
The plasmid DNAs which were engineered during the course of this thesis work 
were constructed utilizing the protocols presented in section 3.5 of this document. Table 
3.3 lists the names of the plasmids produced, their parent vector, cloning sites and insert 
origin. 
Table 3.3 Overview of Plasrnids Produced in this Thesis Work 
The plasmids engineered during the course of this 
groupings, those which were utilized as templates for in 
thesis work fall into two main 
vitro transcribed ribonuclease 
protection analysis RNA probes and those which were expression vectors utilized in the 
production of stable rat hepatoma cell lines. The following paragraphs will briefly define 
the cloning strategies for each vector produced and reference the original citing for other 
vectors utilized during the construction. 
The template utilized to produce a C/EBPa antisense RNA probe for ribonuclease 
protection analysis (19R-C/EBPa) was constructed by ligating the BamHI/ Pstl fiagment 
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of pMSV-C/EBPa (Friedman, et al. 1989), corresponding to nucleotides +13 1 to +782 of 
the rat CEBPa cDNA sequence, into BamHI ! Psti digested pTZ-19R (United States 
Biochemical). This vector was linearized for probe production by digestion with AvaI 
which cuts at nucleotide +450 of the rat C/EBPa cDNA sequence, producing a 370 
nucleotide RNA probe which protected 332 nucleotides of the CIEBPa mRNA. 
The vector which was utilized as a template for ribonuclease protection analysis 
antisense RNA C/EBPP probes (1 8R-LAP) was constructed by ligating the Psti / Psti 
fragment of pSCt-LAP (Descombes, et al. 1 990), corresponding to nucleotides +246 to 
+736 of the rat C/EBPP cDNA sequence, into the Psti site of pTZ-18R (United States 
Biochemical). Antisense orientation of insert containing clones was confirmed by 
digestion with Smal at room temperature, where vectors containing insert in the proper 
orientation yielded an approximately 280 bp fragment. This vector was linearized for 
probe production by digestion with Hind111 which cuts at nucleotide +3 10 of the multiple 
cloning site of pTZ-18R, producing a 545 nucleotide RNA probe which protected 490 
nucleotides of the CEBPP mRNA. 
The vector utilized as a template for the production of ribonuclease protection assay 
antisense RNA PEPCK probes (1 9R-PCK L 0) was constructed by ligating the EcoNl BgiII 
fragment of PCKlO (Yoo-Warren, et al. 1983), corresponding to nucleotides +70 to +300 
of the rat PEPCK cDNA sequence into the EcoRI l BamHl sites of pTZ- 19R. The vector 
was linearized for probe production by digestion withXbalwhich cuts at position +285 of 
pTZ- 19R, producing a 238 nucleotide probe which protected 230 nucleotides of the rat 
PEPCK-C rnRNA. 
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The vector utilized as a template for ribonuclease protection analysis RNA probes 
for the detection of C/EBPP antisense RNA ( I  9R-LAP) was constructed by ligating the 
PstI / Psti fiagment of pSCt-LAP into the Pstl site of pTZ-19R. Sense orientation was 
c o b e d  by digestion of insert containing clones with SmuI at room temperature, where 
vector containing insert in the proper orientation would yield an approximately 180 bp 
f-ent. This vector was linearized for probe production by digestion with EcoRlwhich 
cuts at nucleotide +315 of the multiple cloning site of pTZ-19R, producing a 550 
nucleotide probe which protected 490 nucleotides of the CEBPf3 antisense RNA. 
The vector uti 1 ized for the production of ri bonuclease protection assay probes for 
detection of C/EBPa antisense RNA was produced by ligating the EcoRI I BUMHI 
hgment of pGaN 1 75 (Roesler, et al. 1 W8), corresponding to nucleotides + 1 1 7 to +658 
of the rat C/EBPa cDNA sequence, into the EcoRIl BamHIsites of pTZ- 18R. This vector 
was linearized for probe production by digestion with HindIIi which cuts at position +3 10 
of the pTZ-18R multiple cloning site, producing a 573 nucleotide probe which protected 
541 nucleotides of the CEBPa antisense RNA. 
The expression vector for GBF-F (MSV-GBF-F) utilized in the production of the 
MSV-GBF-F stable H4IIE cell line was constructed by ligating an EcoRII BamHIfragment 
of pRGX-GBF-F (Olive, et al. 1996), wrresponding to full length GBF-F, into the EcoM 
/ BamHI sites of MSV-C/EBPP (Cao, et ul. 1991 ), thus displacing the full-length C/EBPP 
insert. The GBF-F EcoRI / BumHI fhgment was derived h m  pRGX-GBF-F by PCR 
amplification utilizing a forward PCR primer designed to introduce an EcoRI site into the 
5' un-translated region of the GBF-F cDNA sequence. The foward and reverse PCR 
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primers utilized to amplifjl the approximately 400 bp GBF-F E c M  / BomHI b e n t  
fiom pRGX-GBF-F where as follows: 
GBF-F Forward: 5'-TATCGAATTCATGCCAGTGAAGGAT-3' 
GBF-F Reverse: 5'-TATCGGATCCAAGCTTGCCGTC-3' 
The expression vector used to express C/EBPa antisense RNA (MSV-C/EBPa 
anti) was constructed by sub-cloning the P s t l /  BamHI fragment of pMSV-C/EBPa, in 
antisense orientation, into the Pstl / BamHI sites of the multiple cloning site of 
pBluescri pta SK' (Stratagene) to produce p~ lue sc r i p t~  SK+-CEBPa anti. The EcoN / 
BamHI bgment  of pBluescripta SIC+-CEBPa anti was then ligated into the EcoRI I 
BamHl sites of MSV-CEBPP to produce MSV-CEBPa anti. 
The expression vector used to express ClEBPf3 antisense RNA (MSV-C/EBPp anti) 
was constructed by sub-cloning the Pstl fragment of pSCt-LAP into the Psi1 site of 
pBluemipta SK+ to produce pBluescriptm SK+-CEBPP anti. Vectors containing insert in 
the proper orientation were identified by digest with Smal at room temperature, where 
positive clones would yield a 360 bp fragment. The EcoN / BomHI fragment of 
pBluescriptm SK'-CIEBPP anti was then ligated into the EcoRI / BamHI sites of MSV- 
CEBPP to produce MSV-CEBPQ anti. 
The expression vector used to express C/EBPa sense RNA (MSV-GaN 175) was 
constructed by ligating the EcoRIl BUMHI fragment of pGaN175 into the EcoMl BamHi 
sites of MSV-CIEBPP to produce MSV-C/EBPa sense. Vectors containing insert were 
identified by EcoM / BamHI diagnostic digest. 
3.7 Isolation of Total RNA 
Total RNA was isolated from whole liver tissue or  from rat hepatoma H4IIE cells 
using TRIzolN reagent. In the case of total RNA isolation from whole liver tissue, 100 mg 
of tissue was homogenized in 1 rnL of TRlzol'" reagent. In the case of total RNA isolation 
from H4IE cells, 400 pL of TRlzolm reagent was added to each 100 mm plate and the cells 
were lysed by pipetting. In both situations, total RNA was isolated according to the 
manufacturers instructions. The total RNA pellet was dissolved in an appropriate volume 
of DEPC treated water. Total RNA samples were quantified by acquiring the optical 
density of a given sample at 260 nrn, where an OD2, = 1.0 corresponds to 40 pg of pure 
total RNA. The OD,, of each sample was also taken, a ratio of OD,JOD,, = 1.6 to 1.8 
indicated a relatively pure total RNA sample. Total RNA samples were stored at -80 "C 
until use. 
3.8 Synthesis of RNA Probes in viho 
RNA probes utilized in RNAse protection analysis (section 3.9) were synthesized 
in vitro by a protocol based upon that in Sambmk, et ul. (1 989). Briefly, the following 
were added, in order, into a screw-top vial at room temperature: 0.5 pg of the appropriate 
probe template (see section 3.6 for template cloning strategies), 7 mM Dm, 66 pg/mL 
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R N A s e - k  BSA, 18 units of RNA Guard ' placental RNAse inhibitor, I m M  each of the 
three rNTPs other than rUTP, 1X transcription buffer containing, 40 mM Tris-HCI IpH 
7.51, 6 mM MgCl,, 2 rnM spermidhe-HCl and 5 mM NaCl; 20 units of T7 RNA 
polymerase, 20 pM rUTP and approximately 50 pCi of [a3*P]-UTP. The components were 
mixed by a quick-spin in a microfhge and then incubated at 30 "C for 45 min to allow 
elongation of transcripts. AAer this incubation, 20 units of DNAse I was added to degrade 
the DNA template, and the reaction was allowed to incubate for 15 min at 37 OC, after 
which the tubes were placed on ice. Synthesized RNA probes were purified away from 
unincorporated nucleotide by gel exclusion chromatography on G-50 Sephadex- spun- 
columns equilibrated with TEN buffer at 4 OC. TEN buffer contains 10 m M  Tris-HC1 IpH 
8.01, 100 rnM NaCl and 1 mM EDTA IpH 8.01. In vitro transcribed RNA probes were 
stored at -80 "C until used. 
3.9 Ribonuclease Protection Analysis 
Ribonuclease (RNAse) protection analysis was generally carried out utilizing 10 
pg of total RNA sample and approximately 350000 cprn of labelled RNA probe 
synthesized as outlined in section 3.8. Total RNA and labelled probe were placed in a 1.5 
rnL microfbge tube, 5 units of RNAse fk RQI DNAse was added and was allowed to 
incubate at 3 7 " C for 20 min. After DNAse treatment, the RNA was dried down in a 
vacuum centrifuge. The dried RNA pellet was solubilized in 20 pL of RNAse protection 
hybridization buffer containing 8096 formamide, 40 mM PIPES ipH 6.41, 1 mM EDTA 
[pH 8.0) and 400 mM NaCI. It should be noted that all formamide used for RNA work was 
de-ionized by mixing with AG@ 501-X8 mixed bed resin and was then filtered. The 
RNAse protection samples were then denatured by boiling for 4 min and then allowed to 
hybridize at 42 OC overnight. The next morning, the RNAse protection samples were 
digested by the addition of 350 pL of RNAse digestion buffer containing 10 rnM Tris-HCl 
b H  7.41, 250 rnM NaCl, 5 mM EDTA [pH 8-01, 1 1  p g / d  RNAse A and 4 units of 
RNAse T,, followed by incubation at 30 "C for 20 min. The RNAse digested samples 
were then treated with 0.5% SDS and 65 pg/mL proteinase K at 37 "C for 20 min. The 
samples were then extracted with 400 pL of phenol : chloroform (1 : I), where after 350 pL 
of the aqueous phase was removed to a fresh 1.5 mL rnicrofbge tube. The protected total 
RNA - RNA probe hybrids were precipitated with the addition of 10 pg of yeast total RNA 
and 1 mL of absolute ethanol and incubation at -20 "C for 30 min. The precipitated RNA 
hybrids were pelleted by centrifugation at 1 2 000 rpm at 4 " C for 1 5 rnin. The radioactive 
supernatant was removed and the pellet washed in DEPC treated 70% ethanol, and the 
pellet allowed to dry at 37 "C for 15 min. After drying, the RNA hybrid pel' .et was 
dissolved in 20 pL of denaturing polyacrylamide gel sample buffer (see section 3.5.6) 
which involved alternate vigorous vortexing and incubation at 37 "C for 5 min periods. 
AAer solubilization of the labelled RNA hybrids in the sample buffer, the samples were 
denatured by boiling for 4 min and then plunged on ice. The denaturing 6% 
polyacrylamide 8 M urea gels used for resolving RNAse protection analysis were identical 
in composition to the sequencing gels outlined in section 3.5.6, and the running buffer for 
electrophoresis was also 0.5X TBE. M e r  loading of the samples onto a Bio-rad Proteana 
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I1 xi cell, electrophoresis was allowed to proceed at 1 20 volts until sufficient resolution of 
the samples had been obtained. Following electrophoresis, the denaturing polyacrylamide 
gels were dried on a vacuum gel drier overnight and then subjected to autoradiography 
using Kodak X-OMAT film at -80 O C .  Autoradiograms were quantified by densitometry 
utilizing the Un-Scan-Itm automated digitizing system (Silk Scientific Inc.). 
3.10 Prepamtion of Random-prime Labelled cDNA Probes 
The DNA fragments utilized for cDNA probe synthesis are listed in Table 3.4. 
DNA fragments used as cDNA probe templates were excised fiom their parent plasmids 
by appropriate restriction enzyrne digests and then gel isolated (section 3 -5.3) and dissolved 
in sterile water at a concentration of approximately 25 ng/& The DNA fbgments were 
first denatured by boiling for 10 min and were then plunged on ice. Probe synthesis was 
begun by adding the following into a screw-top vial on ice: 100 ng of the appropriate DNA 
fragment, 75 p M  dNTP mixture, 1 X hexanucleotide mixture, approximately 50 pCi of [a- 
"PI ICTP, 2 units of labelling grade Klenow fmgment of DNA polymerase I and sterile 
water for a total volume of 20 pL. The hexanucleotide mixture contains, at 1X 
concentration, 50 rnM Tris-HCI [pH 7.21, 10 rnM MgCl,, 100 plbl DTE, 200 pg/rnL BSA 
and hexanucleotides at a concentration of 6.25 A, uniWmL. Random prime probe 
synthesis was allowed to occur for 1 h at 37 "C. Random cDNA probes were purified 
away from unincorporated nucleotide by gel exclusion chromatography utilizing G-50 
Sephadexm spuncolumns equilibrated with TEN at 4 "C. 
Table 3.4 Templates Utilized for Random Prime cDNA Probe Synthesis 
References for pGaN 175 and pRGX-GBF-F can be found in section 3.6 of  this document. 
The parent vector pRIBO was first described by Katz, et 01. (1983). 
3.1 1 Northern Blotting 
Total RNA sample preparation for Northern blotting was conducted as follows: 20 
pg of a given total RNA sample was incubated for 10 min at 65 "C in RNA sample buffer 
containing 1 X MOPS buffer (20 rnM MOPS, 5 mM sodium acetate [pH 7.01 and 1 mM 
EDTA [pH 8.0]), 50% formamide and 16% formaldehyde. Following this incubation 
samples were placed on ice and 2.5 pL of RNA sample loading buffer was added 
containing 50% glycerol and traces of bromophenol blue. Total RNA samples were 
electmphoresized on 1 % agarose / 16% formaldehyde gels which were prepared as follows: 
one gram of agarose was dissolved in 10 mL of 1 OX MOPS buffier and 74 mL of DEPC 
treated water and heated to approximately 80 "C to dissolve the agarose. AAer sufficient 
cooling 16 mL of formaldehyde was added and the gel poured into a horizontal gel cast 
with an appropriate well form. Electrophoresis was conducted utilizing 1 X MOPS as a 
running buffer, RNA samples were loaded and the gel run at 30 volts until an appropriate 
amount of resolution had been achieved. After electrophoresis, the gel was washed in two 
or three changes of DEPC treated water to remove the excess formaldehyde. M e r  these 
washes the gel was soaked in 0.05 N NaOH for 15 min to partially hydrolyse the RNA and 
to facilitate complete transfer to the charged membrane upon capillary elusion. M e r  the 
NaOH soak, the gel was then soaked in 2OX SSC for 45 min at room temperature (20X 
SSC contains 3 M NaCl and 300 mM sodium citrate). The setup for capillary elution was 
essentially as described in Sarnbmk, et 01. (1 989). Following capillary transfer the RNA 
was fixed to the charged membrane by placing the membrane, RNA side up, on three 
pieces of filter paper soaked in 0.05 N NaOH for 20 rnin at room temperature. Following 
this fix the membrane was washed in 6X SSC for 5 min at room temperature. The 
membrane was then pre-hybridized at 65 "C for at least 2 h in a solution containing 5X 
SSPE, 5X Denhardt's solution, 0.5% (wh) SDS, 10Y0 dextran sulphate and 100 pglmL 
denatured salmon sperm DNA. Denhardt's solution was made up as a SOX stock 
containing 1% (wlv) BSA, 1% (wlv) Ficoll400 and 1% (w/v) PVP; SSPE was made up 
as a 20X stock containing 3.6 M NaCl, 200 m M  sodium phosphate and 20 m M  EDTA [pH 
8.01. Afier pre-hybridization, an appropriate amount of labelled cDNA probe (section 
3.10) was denatured by boiling for 5 min and then added to the pre-hybridization solution. 
The membrane in pre-hybridization - cDNA probe solution was then allowed to hybridize 
overnight at 65 "C. Following hybridization, the membrane was washed two times in 2X 
SSPE, 0.1 % SDS for 20 min at room temperature followed by a single wash in 1 X SPPE, 
0.1% SDS for 15 min at 65 OC. The wet membrane was heat-sealed in plastic to prevent 
it from drying and subjected to autoradiography utilizing K& X-OMAT film at -80 "C. 
3.12 RNA Slot Blotting 
Prior to application of RNA samples to the charged membrane by slot blotting, the 
membrane itself was wetted in 6X SSC buffer and assembled in a Bio-Rad Bio-DotaSF 
slot-blot manifold. Each of the manifold's slots were pre-washed with 500 p.L of 6X SSC. 
Total RNA samples were combined with three volumes of RNA slot-blot loading buffer 
containing 50% fonnarnide, 16% formaldehyde and 1X MOPS buffer and were then 
incubated at 65 "C for 5 min. AAer incubation, samples were placed on ice and one 
volume of ice-cold 20X SSC was added. Each of the total RNA samples was then applied 
to an individual slot of the manifold and washed through with 500 pL of 6X SSC. Atter 
application of the total RNA samples, the manifold was disassembled and the charged 
membrane was fixed with alkali by placing it RNA side up upon several layers of filter 
paper soaked in 0.05 N NaOH for 5 min at mom temperature. Following alkali fixation, 
the membrane was briefly washed in 2X SSC. The membrane was then pre-hybridized for 
2 h at 42 "C in a solution containing 5X SSPE, 5X Denhardt's solution, 0.5% (w/v) SDS, 
10% dextran sulphate, 50% formarnide and 20 pg/mL denatured salmon sperm DNA. 
After pre-hybridization denatured 18s-RIB0 cDNA probe was added at approximately 1 
x 106 cpm/ml and allowed to hybridize overnight at 42 "C. AAer hybridization, the 
membrane was washed, initially in two washes of 2X SSPE, 0.1 % SDS for 10 min at room 
temperature, followed by one wash in 1 X SPPE, 0.1% SDS for 15 min at 65 "C and a final 
wash in 0.1 X SSPE, 0.1 % SDS for 10 min at 65 "C. The membrane was then heat sealed 
in plastic and subjected to autoradiography utilizing Kodak X-OMAT film at -80 "C. 
3.13 Harvesting of Protein Lysates 
After appropriate experimental manipulations (see section 4), adherent cells or 
whole rat liver were washed in several mL of ice-cold 1 X phosphate-buffered saline (PBS). 
Phosphate-buffered saline contains 140 m M  NaCl, 27 m M  KC], 100 mM Na&PO, - 7 H,O 
and 18 mM KH,PO,, all buffered to a pH of 7.4. Whole rat liver was homogenized in a 
suitable volume of ice-cold RIPA buffer and then incubated on ice for 30 min. After 
washing, adherent cells were scraped from the plates into 200 pL of RIPA buffer and 
placed into pre-chilled 1.5 rnL microhge tubes and then incubated on ice for 30 min. 
RLPA buffer contains 1 X PBS, 1 % Nonidet NP-40, 0.5% (w/v) sodium deoxycholate, 0.1 % 
SDS, 100 pg/rnL PMSF, 2 pg/mL aprotinin, 1 mM sodium orthovanadate and 1 pg/mL 
pepstatin A. Following incubation on ice, lysate samples were sonicated for 5 sec at a 75% 
setting. Lysate samples were then centrifuged at 12 000 rpm for 15 min at 4 "C to pellet 
cellular debris. Following centrifbgation, the supernatant was removed to a h h  tube and 
this lysate was stored at -80 "C until use. An aliquot of the lysate was first removed 
however, and an appropriate volume of 5X protein lysate sample buffer was added and the 
sample boiled for 5 min whereupon it was analysed by SDS-PAGE. Protein lysate sample 
buffer contains 50 mM Tris-HC1 [pH 6.81, 2% SDS, 400 mM 2-mercaptoethanol, 10% 
glycerol and traces of brornophenol blue. Protein lysates were quantified using Bio-Rad 
Protein Assay Dye reagent in a protocol based upon that first described by Bradford, et al. 
(1 976). 
3.14 Electrophoresis of Protein Lysates on SDS-PAGE 
Protein lysates were generally resolved on 10 % SDS-PAGE gels which contained 
10 % acrylarnide : N,N7-methylene-bis-acrylamide (29.2 : 0.8), 375 m M  Tris-HCl [pH 8.81 
and 0.1 % SDS in the resolving gel, and 5% acrylarnide : N,N'-methylene-bis-acrylamide 
(29.2:0.8), 130 rnM Tris-HC1 IpH 6.8) and 0.1% SDS in the stacking gel. Polymerization 
was initiated by the addition of 0.1% APS and 0.04% TEMED. The d n g  buffer utilized 
for SDS-PAGE contained 25 mM Tris-HC1,250 m M  glycine IpH 8.31 and 0.1% SDS. In 
order to partially confirm that protein lysates had been appropriately quantified, an 
equivalent amount of each lysate, generally 20 pg, was run out on 1W SDS-PAGE gels 
loaded into Bio-Rad Mini Proteana II apparatus, at 120 volts, constant voltage until the 
bromophenol blue dye marker had just run off the gel. The gels were then stained in 
Coomassiem Brilliant Blue stain for 20 min and then destained in a buffer containing 300/0 
methanol and 10?4 acetic acid. An equivalent amount of staining in each lane indicated 
relatively good quantification and such lysates where then deemed suitable for Western 
analysis. 
3.15 Western Blotting 
Quantified protein lysates in SDS-PAGE sample buffer, generally 20 pg, were 
loaded onto 10% SDS-PAGE gels with appropriate protein molecular weight standards and 
resolved at 90 volts, constant voltage, until the bromophenol blue tracker dye had passed 
through the stacking gel. The voltage was then increased to 120 volts, constant voltage and 
electrophoresis was allowed to proceed until the tracker dye had just run off the gel. 
Resolved protein lysates were then transferred to nitrocellulose membranes utilizing a Bio- 
Rad Trans-blot apparatus, operated at 120 constant volts for 45 min at 4 "C. The transfer 
buffer used in the trans-blot contained 39 mM glycine, 48 m M  Tris-HC1 and 20% 
methanol. After transfer, the nitrocellulose membranes were briefly washed in PBST 
buffer containing 1X PBS and 0.04% Tween-20. Nitrocellulose membranes were then 
blocked in PBST buffer containing 5% Bio-Rad Blotting Grade Blocker Non-Fat Dry-Milk 
for 2 h at room temperature. Following blocking the membranes were placed in fiesh 
PBST buffer containing 5% blocking reagent as well as a 1 : 1000 dilution of the appropriate 
rabbit primary antibody. The membranes and antibody were then allowed to hybridize with 
gentle shaking at 4 "C overnight. After overnight hybridization, the membranes were 
washed three times for 5 min each in fresh PBST buffer containing 5% Bio-Rad blocking 
reagent. A 1 : 1 0 000 dilution of goat anti-rabbit secondary antibody conjugated to horse 
radish peroxidise was then added and allowed to hybridize with the membrane for 45 min 
at room temperature. Following this final hybridization, the membranes were then again 
washed three times for 5 min each in PBST buffer containing 5% Bio-Rad blocking 
reagent, followed by several brief washes in straight PBST buffer. Antibody-protein 
complexes were then visualized utilizing the NEN-Mandel Renaissancea 
chemilminescent detection kit and Kodak X-OMAT film at room temperature. 
Autoradiograms were quantified by densitometry utilizing the Un-Scan-Itm automated 
digitizing system (Silk Scientific Inc.). 
3.16 Preparation of Stable Transfated Rat Repatoma H4IIE Cells 
The protocols for production of expression vectors utilized in the production of 
stable cell lines have been outlined in section 3.6. Prior to the day of tnrnsfection wild-type 
rat hepatoma H4IIE cells were passaged with a 1:4 dilution so as to render them at 
approximately 50-70% confluence the next morning. The next day the cells were 
transfected with 1 5 pg total DNA per plate. Cells were transfected with an appropriate 
expression vector and a vector containing a selectable marker for gentamkin (0418) 
resistance, pSV,-neo (InforMax, Inc.). The molar ratio of selectable marker vector to 
expression vector utilized was approximately 1:lO. The transfection mixture was 
composed of two separate solutions which were combined slowly, dropwise, and then 
incubated for 30 min at room temperature to allow the formation of a fine CaC1,-DNA 
precipitate. The fmt  solution contained appropriate amounts of expression vector and 
pSV,-neo in sterile water and contained 250 rnM CaCl, (125 mM final concentration in 
complete transfection mix). The second solution contained 50 mM HEPES IpH 7.21 (25 
m M  final), 250 m M  NaCl (1 25 mM final) and 1.5 m M  NaPO, ipH 7.01 (750 find). 
After formation of the transfection precipitate the cell media was aspirated and plates were 
washed with PBS. The transfection mix was then applied in a volume of 1 mL per plate 
and allowed to remain in direct contact with the cells for 20 min at room temperature. 
Following this incubation, 9 mL of cell culture media was added to the plates and they 
were then allowed to incubate for 6 h at 37 "C and 5% CO,. Following this incubation the 
cells were glycerol-shocked by applying 2 rnL per plate of a solution containing 25 mM 
HEPES ipH 7.2],125 rnM NaCl and 1 5% glycerol. This solution was allowed contact with 
the cells for 2.5 min at 3 7 "C, where upon it was diluted out by addition of large volumes 
of cell culture media which was promptly aspirated. The plates were then washed two or 
three times with PBS and then 10 mL of fresh cell culture media was added to each plate. 
The transfected cells were allowed to incubate for at least 48 h at 37 "C and 5% CO, 
whereupon, if they were confluent, they were passaged with a 1 :4 dilution into cell culture 
media containing 400 pg/rnL gentamicin (G4 1 8). Selection was allowed to proceed until 
individual clones had reached a diameter of 3-4 mrn whereupon they were isolated in 
separate 24-well plate wells in media containing 100 pg/mL gentamicin (G4 18). As clones 
reached confluence, they were transferred up to increasingly larger diameter wells until 
they could be passaged with dilution in 100 mm plates, and at this point liquid nitrogen 
DMSO cell stocks were prepared and expression analysis could begin. All stable cell lines 
were cultured indefinitely in 100 pg/mL gentamicin (G4 1 8) to maintain selection pressure. 
4. RESULTS 
4.1 Hormonal Regulation Studies 
4.1.1 Rationale for Use of the Rat Hepatoma H4IIE Cell Line 
The rat hepatoma H4IIE cell line was chosen for studies examining the hormonal 
regulation of liver expressed C/EBP isofoms because of its known sensitivity to the 
hormones of interest and its documented similarity to the differentiated hepatocyte (Pitot, 
et al. 1964). In addition, much of the work done to defbe the hormonal sensitivity of the 
PEPCK-C gene was performed in this cell line (Sasaki, et al. 1984; Faber, et 01. 1993 and 
O'Brien, et a!. 1994), which provided a convenient internal control to ensure that an 
applied hormone was having a measurable effect on gene expression within the cell. 
4.1.2 Effect of Hormones on mRNA Accumulation of C/EBP Isoforms in Rat 
Hepatoma H4IIE Cells 
The first experiment conducted was designed to confirm that the H 4 E  cell line 
was indeed responsive to the hormones which were to be utilized within the study. Prior 
to treatment with hormones, cells were serum-starved by aspirating off the serum- 
containing DMEM cell medium, washed with PBS, and refed with 6esh DMEM medium 
lacking serum and then incubated for 24 hours. The cells were then treated with hormones 
for 4 hours, either as individual treatments or in various combinations with other 
hormones. After the treatment total RNA was isolated from the cells and the changes in 
PEPCK-C mRNA were determined by ribonuclease protection analysis (Figure 4.1 shows 
a representative autoradiogram). The result of this analysis revealed that H4IIE cells were 
indeed a suitable model system to study changes in gene expression induced by hormonal 
signals, as the effects of hormones upon PEPCK-C mRNA levels within these cells were 
as expected (see section 2.2.2). The hormones utilized in these studies included insulin, 
the synthetic glucocorticoid dexamethasone (Arth, et af. 1 958) and glucagon, whose effects 
were induced indirectly by application of the CAMP analogue 8-chlorophenylthio - cyclic 
adenosine monophosphate (8-CPT-CAMP). The use of 8-CPT-CAMP and other CAMP 
analogues to mimic the effects of glucagon has been described previously in the literature 
(Sasaki, et a/. 1984 and Park, et al. 1993). These analogues afe of particular value in cell 
culture-based systems in that they can pass directly through the cell membrane and thus do 
not necessarily require the expression of the glucagon receptor by the cell, as well as 
having been proven to be resistant to the effects of CAMP phosphodiesterases (Beebe, et 
al. 1985). 
Having confirmed the hormonal responsiveness of the H4IE cells, the 
characterization of the patterns of C/EBPa and CEBPP hormonal regulation were 
undertaken. H4IlE cells were serum-starved overnight and then treated for 4 and 8 hours 
with various hormones, independently or in combination. Total RNA was then isolated 
from the cells and subjected to ribonuclease protection analysis. 
Figure 4.1 The effect of various hormonal treatments on PEPCK-C mRNA 
accumulation in H 4 E  cells. Changes in PEPCK-C mRNA accumulation were 
assessed by ribonuclease protection analysis as outlined in section 3.9. The 
hormones with which H4IIE cells were treated included 200 ph4 8-CPT-cAMP 
(CAMP), 5 n M  insulin and 1 p M  dexamethasone (Dex). All hormonal 
treatments were for a 4 hour time period. The equilibration of RNA amounts 
between samples was verified by RNA slot-blot analysis using an 18s rRNA 
probe as described in section 3.12 (data not shown). 
Figure 4.2a shows representative autoradiograms and the averages of four independent 
experiments and Figure 4.2b displays the means * S.E. of four independent experiments 
in a graphical format; revealing the changes in C/EBPa and C/EBPp mRNA levels relative 
to controls after treatment with various hormones. 
One of the most outstanding observations arising from these experiments was the 
robust induction in both C/EBPa and C/EBPP mRNA accumulation as a result of 
dexamethasone treatment of rat H4IIE cells either alone or in combination with other 
hormones. The effects of dexarnethasone on C/EBPa mRNA were most significant at the 
4 hour time point where levels were increased 3-fold on average over controls. This 
inductive effect was diminished to a 2-fold increase over control by the 8 hour time point. 
The effect of dexamethasone on C/EBPP mRNA accumulation was greater than that on 
C/EBPa, increasing C/EBPP mRNA Cfold over control at the 4 hour time point and 
increasing to 8.5-fold over controls on average by 8 hours. Furthermore, when 
dexamethasone was applied to H4IIE cells in various combinations with the other 
hormones, its effects upon C/EBPa and CEBPP mRNA levels were generally additive 
with the effects of the other hormones. Thus it would appear that glucocorticoids are a 
dominant activator of C/EBP expression within the rat hepatoma cell. 
The effects of 8-CPT-CAMP upon C/EBPa mRNA accumulation were modest at 
best, with the largest induction being 2-fold on average at 8 hours. The effects of 8-CPT- 
CAMP on C/EBPP mRNA accumulation were greater than its effects on C E B P a  mRNA, 
with a average 2-fold induction of CEBPP message levels observed at the 4 hour time 
point which increased to 4.5-fold by 8 hours. When 8-CPT-CAMP was applied to H4IE 
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Fi y r e  4.2. The effects of various hormonal treatments on C/EBPa and C/EBPf3 
mRNA accumulation in H 4 I E  cells. Changes in -A accumulation were 
assessed by ribonuclease protection analysis as outlined in section 3.9. H 4 E  
cells were treated with either 200 @I 8-CPT-CAMP (cA), 5 n M  insulin (I), 1 pM 
dexamehsone @ex) or various combinations thereof for4 and 8 hours; controls 
are abbreviated as CTX. Each panel shows a representative autoradiogram, the 
values below are the relative mRNA level (where controls were assigned a value 
of 1) averaged from four independent experiments. The equilibration of RNA 
amounts between samples was verified by RNA slot-blot analysis using an 18s 
rRNA probe as described in section 3.12 (data not shown). 
Figure 43b Graphical representation of the effects of various hormonal 
treatments on CEBPa (Panels A and B) and C/EBPP (Panels C and D) mRNA 
accumulation in H41IE cells. Changes in mRNA accumulation were assessed by 
ribonuclease protection analysis as outlined in section 3.9. H411E cells were 
treated with either 200 pM 8CPT-CAMP (cA), 5 nM insulin (I), 1 mM 
dexamethasone (Dex) or  various combinations thereof for 4 and 8 hours. The 
levels of C/EBPa or C/EBPP mRNA in untreated cells were arbitrarily assigned 
a value of I .  The above graphs displays the means i S.E. of four independent 
experiments. 
cells in combination with dexarnethasone, the effects on C/EBPa and CEBPP message 
were generally additive. However, when 8-CPT-CAMP was applied to H 4 I E  cells in 
combination with insulin there were no additive effects upon C/EBP isoform expression. 
An interesting exception is the effect of CAMP and insulin in combination upon C/EBPa 
mRNA in H4IIE cells at the 4 hour time point, where a 2.5-fold on average induction was 
observed, although 8-CPT-CAMP generally had no effect on C/EBPa expression at this 
time point and insulin alone was seen to be inhibitory. 
The effect of insulin upon C/EBPa message accumulation appeared to be bi-phasic, 
in that at the 4 hour time point insulin appeared to inhibit C/EBPa expression by 500/a, 
wheteas by the 8 hour time point a 2-fold induction of CEBPu mRNA over control was 
observed. Insulin inhibited the inductive effect of dexarnethasone on CIEBPa mRNA 
levels at the 4 hour time point, but was roughly additive with the inductive effect of 
dexamethasone on CEBPa expression by 8 hours. Unlike the effects of insulin upon 
C/EBPa expression within H4iIE cells, insulin induced CEBPQ expression (approximately 
4-fold) at both time points measured. 
In order to insure that equivalent amounts of RNA were utilized for each sample 
in all RNA based protocols, 5 pg from each experimental sample was subjected to RNA 
slot-blot analysis using an 1 8s ribosomal RNA cDNA probe, where equivalent 18s rRNA 
signals were considered to be indicative of acceptable RNA sample equilibration. Figure 
4.3 shows a representative autoradiogram of an 18s rRNA slot-blot prepared using the 
RNA samples utilized in the ribonuclease protection analysis shown in Figwe 4.2. 
Figure 4 3  A representative autoradiogram of a 1 8s ribosomal RNA slot-blot 
of the total RNA samples utilized in the ribonuclease protection analysis 
shown in Figure 4.2. Total RNA samples isolated as outlined in section 3.7 
were subjected to RNA slot-blot analysis as outlined in section 3.1 2. Total 
RNA samples weie considered to be of equivalent amounts if the 18s rRNA 
signal of an individual sample did not vary by more than 10% from the other 
samples. The 18s rRNA signal could be quantified either by densitometxy or 
by liquid scintillation counting of the individual "slots" of the charged 
membrane. 
It should also be noted that, in order to insure that the changes in CEBP isoform 
gene expression observed were specific, the mRNA levels of the CAMP response element 
binding protein (CREB) were also assessed (data not shown), and were observed to be 
idtered in comparison to controls in all treated samples. This tlnding was in agreement 
with previously published work which had demonstrated that CREB mRNA levels are not 
hormonally regulated in rat liver or rat liver-derived cells (Crosson, et al. 1996). 
4.13 Efflect of Hormones on the Protein Levels of CfEBPa and C/EBP@ in Rat 
Hepatoma H4IIE Cells 
The next area of experimentation involved determining whether the effects of 
various hormones on C/EBPa and C/EBPP expression at the level of mRNA accumulation 
corresponded to changes observed in the steady-state levels of C/EBP isoform proteins. 
Western analysis was performed on protein lysates prepared fiom hormone-treated H4IIE 
cells at 8 and 16 hour time points. The time points used in this study were greater than 
those used for the analysis of mRNA accumulation in order to allow CEBP isofonn 
proteins to accumulate to a steady-state level following gene transcription. Figure 4.4a is 
a representative autoradiogram of four independent experiments, while Figure 4.4b 
displays the means * S.E. of four independent experiments in graphical format. The 
protein levels of the RNA polymerase II general transcription factor TFIIEcr were also 
assessed in each lysate in order to insure an equivalent amount of total protein had been 
utilized for each sample subjected to Western analysis. In general, the changes in C/EBPa 
Figure 4.4a The effect of various hormonal treatments on C/EBPa and 
C/EBPP protein levels in H 4 i E  cells. Changes in protein accumulation were 
assessed by Western analysis as outlined in section 3.15. H4IIE cells were 
treated with either 1 mM 8-CPT-cAMP (cA), 5 nM insulin (I), 1 p M  
dexamethasone (Dex) or various combinations thereof for 8 and I6 hours. 
Controls are abbreviated as Ctx. Each panel shows a representative 
autoradiogram of four independent experiments. The equilibration of protein 
amount between samples was confirmed by assessing the protein levels of the 
general transcription factor TFIIEa. 
Figure 4Ab Graphical representation of the effects of various hormonal treatments on 
C/EBPa (Panels A and B) and C/EBPP (Panels C and D) protein levels in H411E cells. 
Changes in protein accumulation were assessed by Western analysis as outlined in section 
3.15. H411E cells were treated with either I m M  SCPT-cAMP (cA), 5 nM insulin (I), 1 
rnM dexamethasone (Dex) or various combinations thereof for 8 and 16 hours. The levels 
of ClEBPa or CIEBPP protein in untreated cells were arbitrarily assigned a value of 1. 
The above graphs displays the means * S.E. of four independent experiments. 
and C/EBPP protein levels directly parallelled the changes observed in mRNA 
accumulation. The most notable effects upon CEBP protein levels were caused by 
dexarnethasone, which parallelled the changes observed in mRNA accumufation. 
Treatment with CAMP had a slight inductive effect upon CEBPa protein levels at both 
time points. The induction of CEBPQ protein levels by CAMP appeared to be more 
significant than that of CEBPa, but was more acute in that the inductive effect was only 
sustained up to the 8 hour time point. Insulin also induced CEBPP protein levels up to the 
8 hour time point. The inhibitory effect of insulin upon C/EBPa mRNA accumulation was 
also observed at the level of its protein, however the effect appeared to be delayed in that 
it did not appear until the 16 hour time point. The changes in C/EBPa and C/EBPP protein 
levels as a result of combination hormonal treatment were generally not additive, and 
fiutherrnore insulin was seen to inhibit the effects of both CAMP and dexarnethasone on 
C/EBPa protein levels at both the 8 and 16 hour time points, much Iike what was observed 
with changes in C/EBPa mRNA accumulation at the 8 hour time point. 
4.1.4 Effkct of CAMP Bolus on C/EBP Isofom mRNA Levels in Rat Liver 
The aforementioned studies regarding the effect of CAMP upon CEBP isoform 
mRNA accumulation and protein levels had suggested that the p-isoforrn of CEBP was 
more responsive to this second messenger than was the a-isofonn in a hepatoma cell line. 
We also wished to determine whether C/EBP isoforms were regulated in vivo by CAMP 
within the intact rat liver. As outlined in section 3.4, male Sprague-Dawley rats were 
subjected to a theophylline / 8-CPTcAMP bolus, total RNA was isolated from their livers, 
and the effect of the CAMP bolus upon CEBP isoform rnRNA accumulation was assessed 
by ribonuclease protection analysis. Figure 4.5 shows the results of this 8-CPT-CAMP 
bolus experiment. No significant difference was observed in hepatic C/EBPa rnRNA 
levels between control and 8-CPT-CAMP treated rats. This observation correlates with the 
relatively minor effects of 8-CPT-CAMP upon CEBPa mRNA accumulation within the 
rat hepatoma H4IIE cell line (section 4.1.2). The levels of C/EBPP mRNA however, were 
elevated nearly Ffold over controls in the livers of the same treated animals, indicating that 
the i n  cyfo observation that C/EBPP is the major 8-CPT-CAMP regulated hepatic C/EBP 
isoform can be extended into the in vivo setting. In order to assess whether changes in 
C/EBP isoform expression were unique, the levels of PEPCK-C and CREB rnRNA were 
also measured (data not shown). The levels of PEPCK-C mRNA were considerably 
elevated over controls in the livers of CAMP bolus treated rats and the levels of CREB 
mRNA were unchanged, as would be expected based upon previous findings (section 2.2.2 
and Crosson, et UZ. 1996, respectively). 
4.15 Effect of Streptozotocin-Diabetes on C/EBP Isoform Expression in Rat Liver 
Given that the results presented in section 4.1.2 thru 4.1.4 demonstrated that hepatic 
CEBP isoforms are regulated by glucose homeostasis-affecting hormones, and because of 
the acknowledgment that C/EBP isoforms are important regulators of energy homeostasis 
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Figure 4.5 ERect of 8-CPTcAMP on the mRNA levels of C/EBPa and CEBPP in rat 
liver. Male Sprague-Dawley rats were given intraperitonial injections of 8-CPT- 
cAMP/theophylline (CPT-CAMP, n=4) or saline carrier (Controls, n=3) as outlined in 
section 3.4, total RNA was then isolated fiom the livers (section 3.7) and analysed for 
the levels of CEBPa and C/EBPP mRNA by ribonuclease protection analysis (section 
3.9). The equilibration of RNA amounts between samples was verified by RNA slot- 
blot analysis using an 18s rRNA probe as described in section 3.12 (data not shown). 
Values shown are the means * S.E.. 
(section 2.3.3), we next examined the effects of streptozotocin-induced diabetes on hepatic 
C/EBP isofonn expression. The effects of diabetes and subsequent insulin treatment upon 
mRNA levels of C/EBPa and CEBPP in rat liver are shown in Figwe 4.6. The levels of 
C/EBPP mRNA were not altered in streptozotocin-diabetic rat livers and subsequent 
insulin treatment had no m e r  effect. However, the levels of C/EBPa mRNA in diabetic 
rat liver were reduced by 60-80% relative to controls as assessed by densitometry. 
The levels of CEBPa and C/EBPP proteins were also assessed in these same livers 
by Western analysis (Figure 4.7). No change was seen in either of the translation forms of 
CEBPP (section 2.3.1.3) in streptozotocin-diabetic or diabetic-insulin treated rat livers 
relative to controls. The levels of C/EBPa protein were decreased in diabetic and insulin- 
treated rat livers, parallelling the change observed in its mRNA accumulation. However, 
in streptozotocin-diabetic rat liver a distinct difference in the reduction of the individual 
alternative translation forms of C/EBPa was observed (section 2.3.1 -3). There was a 
significant 50-60% decrease in the smaller 29 kDa form of C/EBPa, but only a moderate 
25% decrease in the levels of the transcriptionally active, 111 length 42 kDa form of 
CEBPa. Insulin treatment of the diabetic rat livers was seen to restore the levels of both 
CEBPa  translation products to control levels, if not slightly elevating the levels of the 42 
kDa form over that of controls. 
It should be noted that all results presented in section 4.1 of this thesis have been 
reported in Crosson, et al. (1997). 
Figure 4.6 Effect of diabetes and insulin treatment on CEBPa and C/EBPP mRNA 
accumulation in rat liver. Rats were made diabetic and subsequently treated with 
insulin as outlined in section 3.4. Total RNA isolated from rat livers (section 3.7) 
was subjected to ribonuclease protection analysis (section 3.9). The abbreviations 
used are: C - saline controls (n=4); D - streptowtocindiabetic rats (n=4); I - insulin- 
treated diabetic rats (n=4). The equilibration of RNA amounts between samples was 
verified by RNA slot-blot analysis using an 18s rRNA probe as described in section 
3.12 (data not shown). Values shown are the means k S.E.. 
Figure 4.7 Effect of diabetes and insulin treatment on the levels of C E B P a  
and CEBPP proteins in rat liver. Protein levels of  CEBPa, C/EBPP were 
determined by Western analysis as outlined in section 3.13. The abbreviations 
used are: C - saline controls (n=4); D - streptozotocindiabetic rats (n=4); I - 
insulin-treated diabetic rats (n=4). The equilibration of protein amount 
between samples was c o n f h e d  by assessing the levels of the general 
transcription factor TFIIEa (data not shown). 
4.2 Cbancterization of Rat Heprtoma H4IIE Stable Cell Lines and the E f k t s  of 
Inhibition of C/EBP Isoform Activity on PEPCK-C Gene Transcription 
Having characterized the patterns of hormonal regulation of C/EBPu and CEBPP 
within the H4IiE cell line we next set out to characterize a role of CEBP isoforms in the 
mediation of hormonally responsive gene expression. As discussed in section 2.2.3.1.3, 
the requirement of CEBP for the basal and CAMP inducible expression of PEPCK-C has 
been well characterized. However, previous in cy fo  studies based on synthetic promoter 
systems and over expressed transcription factors have not been successll in identifjing 
the specific CEBP isoforms required to mediate particular transcriptional responses of the 
PEPCK-C gene. In fact recent work by Park, et d. (1999), has suggested that the two main 
hepatic C/EBP isoforms, a and P, can act interchangeably to mediate CAMP 
responsiveness when bound to the PEPCK-C promoter. While serving well to suggest the 
potential for a given factor(s) to mediate a certain transcriptional response, such synthetic- 
based experiments cannot reflect the molecular mechanisms which occur in an endogenous 
setting with absolute certainty. In order to address the nature of these endogenous 
mechanisms, a experimental system must be designed which allows the transcription 
factors of interest to be manipulated or otherwise altered so that their role in the 
transcriptional mechanisms of an endogenous promoter can be interpreted. Methodologies 
by which the activity of cellular proteins can be altered have been discussed in section 2.4. 
In order to determine the specific identity of the hepatic C/EBP isoform absolutely required 
to mediate the CAMP responsiveness of the endogenous PEPCK-C promoter, a number of 
stable cell lines have been prepared which express specific molecules designed to inhibit 
generalized or specific CEBP isoform activity (see sections 2.4.1 and 2.4.2). 
H 4 E  stable cell lines expressing either GBF-F, C/EBPa or C/EBPP antisense 
RNA or C/EBPa sense RNA were prepared as outlined in section 3.16. A number of 
clones of each cell line were examined for the levels of expression of the specific gene of 
interest (data not shown). The strongest expressing clone was selected for further 
characterization and was thereafter propagated exclusively. As a matter of general note all 
results shown in the following sections are representative of at least three independent 
experiments and quantitative values presented are the averages of at least three 
experiments. 
4.2.1 Characterization of the CBF-F D4 H4IIE Cell Line 
In order to confirm the general requirement of CEBP isoforms for PEPCK-C basal 
and CAMP inducible expression, a H4IIE cell line was prepared which expresses a 
dominant negative inhibitor of CEBP isoform activity, GBF-F (see section 2.4.1). High 
levels of GBF-F expression within the intact cell should indiscriminately inhibit the 
transcriptional activity of all CEBP isoforms by the formation of inactive heterodimers. 
The levels of GBF-F expression in the GBF-F D4 clone are shown in panel A of Fig. 4.8. 
Panel B of Fig. 4.8 shows a representative autoradiogram which demonstrates the effects 
of GBF-F expression on CEBPa and C/EBPP mRNA levels in the GBF-F D4 cell line in 
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Figure 4.8 Comparison of wild type H41IE cells (H4-wt) to a H4IIE stable transfected clone 
expressing GBF-F (GBF-F D4). Panel A is a representative Northern blot (section 3.1 I) showing 
GBF-F expression levels in the GBF-F D4 clone in comparison to H41IE wild type cells. The 
equilibration of RNA amounts between samples was verified by RNA slot-blot analysis using an 
18s rRNA probe as described in section 3.12. Panel B shows a representative ribonuclase 
protection analysis (section 3.9) of CEBPa and C/EBPP mRNA levels in the GBF-F D4 clone 
in comparison to H41IE wild type cells. Panel C shows a representative Western blot analysis 
(section 3.15) of CEBPa and C/EBP$ protein levels in the GBF-F D4 clone in comparison to 
H4IIE wild type cells. The equilibration of protein amount between samples was confirmed by 
assessing the protein levels of the general tcanscription factor TFIIEa. The results shown are 
representative of at least three independent experiments. Values reported are means * S.E. of 
three independent experiments. CEBPa  and C/EBPf! mRNA and protein levels in wild type 
H411E cells were arbitrarily assigned a value of 1. 
comparison to wild type H4IIE cells. The expression of GBF-F was observed to produce 
an approximate 30% reduction in CIEBPcx mRNA levels and a 65% reduction in CEBPP 
mRNA levels. Despite the larger repressive effect of GBF-F expression upon CEBPP 
mRNA levels, this effect was not parallelled by its protein; no difference was detected in 
the levels of C/EBPP protein between GBF-F D4 cells and wild type H4IIE cells (as shown 
in panel C of Fig. 4.8). However, the levels of C/EBPa protein were seen to be reduced 
by nearly 60% in GBF-F D4 cells in comparison to wild type H4IIE cells. 
4.2.2 Characterization of the aA B1 H4Ii.E CeU Line 
In order to produce a model system in which to test the requirement for the a- 
isoforrn of CEBP in the hormonal responsiveness of the PEPCK-C promoter, a cell line 
expressing antisense RNA to C/EBPa was prepared. Panel A of Fig. 4.9 shows the levels 
of expression of the C/EBPa antisense RNA in the aA B1 H4IIE cell line in comparison 
to wild type H4IIE cells. As would be expected, the expression of an antisense RNA to 
C/EBPa within the aA B1 H 4 E  cell line inhibited the overall expression of the 
transcription factor. As shown in panel B of Fig. 4.9, the levels of C/EBPa rnRNA were 
reduced by 80% in the C/EBPa antisense expressing aA B 1 cell line in comparison to wild 
type H4IIE cells. Most importantly from the aspect of functional inhibition of C/EBPa 
activity, the levels of C/EBPa protein were also decreased in the aA B 1 cell line by nearly 
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Figure 4.9 Comparison of wild type H4IIE cells (H4-wt) to a H41IE stable tiansfected clone 
expressing CEBPa antisense RNA (aA Bl). Panel A is a representative ribonuclease 
protection analysis (section 3.9) showing CEBPu antisense RNA expression in the uA B1 
clone in comparison to H4IIE wild type cells. Panel B shows a representative ribonuclease 
protection analysis of C/EBPa and C/EBPfl mRNA levels in the aA B 1 clone in comparison 
to H411E wild type cells. The equilibration of RNA amounts between samples was verified by 
RNA slot-blot analysis using an 18s rRNA probe as described in section 3.12 (data not shown). 
Panel C shows a representative Westem blot analysis (section 3.15) of C/EBPa and C/EBPB 
protein levels in the aA B 1 clone in comparison to H411E wild type cells. The equilibration of 
protein amount between samples was w n f m e d  by assessing the protein levels of the general 
transcription factor TFllEa (data not shown). The results shown are representative of at least 
three independent experiments. Values reported are means S.E. of thee independent 
experiments. CEBPa and CEBPf3 mRNA and protein levels in wild type H411E cells were 
arbitrarily assigned a value of 1 . 
80% in comparison to wild type cells (refer to panel C of Fig. 4.9). An interesting 
dichotomy was observed between the effects of C/EBPa antisense RNA expression upon 
CEBPa and CEBPQ expression. The expression of C/EBPa antisense RNA caused an 
opposing effect on CEBPQ expression in that it doubled both C/EBPP mRNA and protein 
levels in comparison to levels in wild type H 4 l E  cells (panels B and C of Fig. 4.9). Thus 
it would appear that C/EBPa expression is significantly inhibited within aA B 1 cells and 
that there is a corresponding increase in the expression of the P-isoform of C/EBP. 
4.23 Characterization of the PA C4 H4IIE Cell Line 
In order to assess the requirements for the p-isoform of CEBP in hormonally 
regulated PEPCK gene expression, a stable H 4 E  cell line was prepared which expresses 
antisense RNA to C/EBPQ. Panel A of Fig. 4.10 shows the level of expression of CEBPQ 
antisense RNA in the PA C4 H4IIE cell line in comparison to H 4 E  wild type cells. 
Parallelling the observations made in the CEBPa antisense RNA expressing cell line aA 
B1, the expression of C/EBPP antisense RNA in the PA C4 H4IIE cell line reduced the 
levels of C/EBPP sense mRNA and protein relative to wild type H4IIE cells. The change 
in C/EBPP mRNA in PA C4 cells as a consequence of CIEBPP antisense RNA expression 
corresponded to a 45% reduction (Fig. 4.10, panel B). 
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Figure 4.10 Comparison of wild type H411E cells (H4-wt) to a H411E stable transfected clone 
expressing C/EBP$ antisense RNA ($A-C4). Panel A is a representative ribonuclease prokction 
analysis (section 3.9) showing CEBPP antisense RNA expression in the PAX4 clone in 
comparison to H411E wild type cells. Panel B shows a representative ribonucfease protection 
analysis of C/EBPa and CEBPB mRNA levels in the PAC4 clone in comparison to ff4IIE wild 
type cells. The equilibration of RNA amounts between samples was verified by RNA slot-blot 
analysis using an 18s rRNA probe as described in section 3.1 2. Panel C shows a representative 
Western blot analysis (section 3. IS) of C/EBPa and CtEBPB protein levels in the $A-C4 clone in 
comparison to H411E wild type cells. The equilibration of protein amount between samples was 
confirmed by assessing the protein levels of the general transcription factor TFIIEa. The results 
shown are representative of at least three independent experiments. Values reported are means * 
S.E. of three independent experiments. CEBPa and C/EBPB mRNA and protein levels in wild 
type H4l JE cells were arbitrarily assigned a value of I. 
A corresponding 70?4 reduction in CEBPP protein levels in comparison to wild type 
H4EE cells was observed in the PA C4 cell line (Fig. 4.10, panel C). Thus the expression 
of CIEBPP antisense RNA within the PA C4 cell line reduced the potential activity of 
CEBPP. Much like the observed dichotomy in C/EBPa and C/EBPP expression patterns 
observed in the aA B 1 cell line, a similar but opposite relationship occured in the PA C4 
cell line as the result of CEBPP antisense RNA expression. The levels of CIEBPa protein 
in the PA C4 cell line were increased by 6-fold on average in comparison to wild type 
H 4 E  cells @anel C of Fig. 4.10). Interestingly, unlike the parallel effect on C/EBPP 
mRNA levels and protein observed in the aA B1 cell line, no change in C/EBPa mRNA 
levels were observed in the PA C4 cell line in comparison to wild type cells. 
4.2.4 Characterization of the GaN175 A3 H4IIE CeU Line 
In order to assess the effects of CEBP isoform inhibition on gene expression 
utilizing a stable transfected cell model system, a suitable control must be produced. Such 
a control must account for possible changes in cellular physiology due to the process of 
stable integration of expression cassettes into the genome, as well as account for the 
possible effects upon cellular metabolism because of the selection process. A suitable 
control was produced by creating a H4IIE stable cell line expressing a sense C/EBPa RNA 
encoding for nucleotides +117 to +658. The levels of CIEBPa sense RNA expression in 
Figure 4.11 Comparison of wild type WIIE cells (H4-wt) to a H4IIE 
stable transfected clone expressing a C/EBPa sense RNA construct 
(GaN175 A3). Panel A is a representative Northern blot (section 3.1 1) 
showing sense C/EBPa RNA construct expression levels in the GaN 175 
A3 clone in comparison to wild type H4IIE cells. The equilibration of 
RNA amounts between samples was verified by RNA slot-blot analysis 
using a 1 8s rRNA probe as described in section 3.12 (data not shown). 
Panel B shows a representative Western blot analysis (section 3.1 5) of 
C/EBPa and CEBPP protein levels in the GaN175 A3 clone in 
comparison to H4UE wild type cells. The equilibration of protein amount 
between samples was confirmed by assessing the protein levels of the 
general transcription factor TFIIEa (data not shown). The results shown 
are representative of at least three independent experiments. 
the GaN 175 A3 cell line in comparison to wild type H4IIE cells is shown in panel A of  
Fig. 4.1 1. As shown by representative autoradiograms in panel B of Fig. 4.1 1, no 
significant difference in C E B P a  or C/EBPf3 protein levels was detected in the GaN175 
A3 cell line in comparison to wild type H 4 E  cells as a consequence of the expression of 
the GaN175 CEBPa sense M A .  
4.2.5 Effect of C/EBP Isoform Inhibition on PEPCK-C CAMP Responsiveness 
The specific goal in producing the aforementioned stable H 4 E  cell lines was to 
determine the identity of the CEBP isoform required to mediate the CAMP responsiveness 
of the endogenous PEPCK-C promoter. Having characterized the expression of GBF-F, 
CEBPa antisense RNA or CEBPP antisense RN A in these cell lines (sections 4.2.1 thru 
4.2.3), and having determined that the antisense expressing lines exhibit significant 
reduction in the levels of the targeted CEBP isoform protein (Figs. 4.9 and 4.1 O), we next 
set out to assess the effects of this inhibition on PEPCK-C CAMP responsiveness. Figure 
4.12a displays representative autoradiograms and Figure 4.1 2b shows a graphical 
representation of three independent ribonuclease protection analysis designed to test the 
C/EBP requirements for PEPCK-C CAMP responsiveness. 
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Figure 4.12~ The effects of  GBF-F, CEBPa antisense, C/EBPP 
antisense or C/EBPa sense RNA on endogenous PEPCK-C CAMP 
responsiveness in stable H4IIE cell lines in comparison to wild type 
H4IIE cel Is. Changes in PEPCK-C mRNA accumulation were assessed 
by ribonuclease protection analysis as outlined in section 3.9. Wild type 
H41IE or stable H411E cell lines were treated with 200 pM 8-CPT-CAMP 
for 4 hours (+); controls are designated as (-). The equilibration of RNA 
amounts between samples was verified by RNA slot-blot analysis using 
an 18s rRNA probe as described in section 3.12 (data not shown). The 
above panels are representative of at least three independent experiments. 
Quantitation of the changes in PEPCK mRNA levels in each cell line 
relative to untreated H4-wt cells are reported in Figure 4.12b. 
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Figure 4.12b Graphical representation of the effects of GBF-F (GBF-F 
D4), C/EBPa antisense RNA (aA B 1 ), C/EBPB antisense RNA (PA C4) 
or C/EBPa sense RNA (GaN175 A3) on endogenous PEPCK-C CAMP 
responsiveness in stable H4IIE cell lines in comparison to wild type H4IIE 
cells (H4-wt). Changes in PEPCK mRNA accumulation were assessed by 
ribonuclease protection analysis as outlined in section 3.9. Representative 
autoradiogram have been shown in Figure 4.12a Wild type H4IIE or stable 
H41IE cell lines were treated with 200 p M  8CPT-CAMP for 4 hours (+); 
controls are designated as (-). The above graph displays the means S.E. 
of three independent experiments. 
In wild type H4lIE cells, a 4 hour 200 @I 8-CPT-CAMP treatment produced an 
approximate 3-fold increase in PEPCK-C mRNA accumulation. The responsiveness of 
PEPCK-C to 8-CPT-CAMP was abolished in the GBF-F expressing cell line GBF-F D4, 
confirming the general requirement of C/EBP isofoms in CAMP responsiveness. 
Furthennore, the general inhibition of C/EBP isofom activity within the GBF-F D4 cell 
line also affected PEPCK-C basal expression, with a 35% reduction in PEPCK-C mRNA 
levels in GBF-F D4 cells in comparison to wild type H4IIE cells. 
The inhibition of CIEBPa activity by antisense within the aA B 1 cell line also 
abolished PEPCK-C CAMP responsiveness (Fig. 4 .12). The levels of PEPCK-C basal 
expression were also reduced in the aA B 1 cell line, where a 70% reduction was observed 
in comparison to wild type cells. 
An inhibition of PEPCK-C CAMP responsiveness was not observed in CIEBPP 
antisense RNA expressing PA C4 cells (Fig. 4.12). In fact, the fold induction of PEPCK- 
C mRNA levels within the PA C4 cell line was routinely observed to be greater than that 
seen in wild type H4HE cells, producing a Sfold increase compared with the 3-fold 
induction observed in wild type H 4 l E  cells. No significant difference in PEPCK-C basal 
expression levels were observed in PA C4 cells relative to H4IIE wild type. 
As expected, no inhibition of PEPCK-C CAMP responsiveness was observed in the 
C/EBPa sense RNA expressing cell line GaN 1 75 A3 (Fig. 4.12). Thus, the processes of 
stable integration and selection appeared not to have interfered with the molecular 
mechanisms of CAMP induction of endogenous PEPCK-C within the stable transformed 
cell lines. 
From this data, it is concluded that CEBPa is the specific CEBP isofonn which 
along with the other characterized CRU binding trans-ac ting factors, together mediate the 
CAMP induction of the endogenous PEPCK-C gene with the H4IIE rat hepatorna cell. 
4.2.6 Effect of C/EBPa Antisense RNA and GBF-F on CeUulrrr CAMP Signalling 
In order to properly interpret the results presented in section 4.2.5 regarding the 
effects of the inhibition of CEBP isofonn activity upon PEPCK-C CAMP responsiveness, 
the possibility that C/EBPa inhibition exerted its effects in an indirect fashion, perhaps by 
affecting the levels of a protein required for general CAMP responsiveness such as CREB 
needed to be addressed. Thus, it was necessary to determine whether CAMP 
responsiveness in general was reduced, or whether it was only CAMP responsiveness 
requiring the presence of C/EBPa affected. The levels of CREB protein were not 
significantly altered in the GBF-F D4 or aA Bl cell lines relative to wild type cells (data 
not shown). The effects of GBF-F and C/EBPa antisense RNA expression upon the CAMP 
responsiveness of a endogenous H 4 E  gene other than PEPCK-C were also assessed. As 
the results displayed in Figs. 4.2 and 4.4 have shown, the gene for C/EBPP is acutely 
affected by 8-CPT-CAMP treatment at the levels of both mRNA and protein. The CAMP 
inducibility of the CEBPP gene is believed to require only the mediation of CREB 
(Niehof, et a/. 1997). In order to determine whether CEBPP protein could still be induced 
by 8-CPT-CAMP in the cxA B1 and GBF-F D4 cell lines these cells were treated with 1 rnM 
8-CPT-cAMP for 8 hours, parallelling the experiment performed in wild type H4IIE cells 
shown in Fig. 4.4. The effect of 8-CPTcAMP treatment of these cell lines upon C/EBPP 
protein was assessed by Western analysis as shown in Fig. 4.13. The levels of CEBPP 
protein were induced by 3-fold on average in both aA B 1 and GBF-F D4 cells, which is 
comparable to the induction observed in wild type H4IIE cells shown in Fig. 4.4. Thus 
it would appear that overall cellular CAMP signalling in the C/EBPa antisense RNA and 
GBF-F expressing cell lines is operating in a manner comparable to that of wild type H4IIE 
cells. This result would suggest that the abolishment of PEPCK-C CAMP responsiveness 
in the C/EBPa antisense RNA and GBF-F expressing cell lines is a unique effect due to 
the down-regulation of  CEBP isoform activity and is not due to some general suppression 
of the CAMP signalling pathway. 
4.2.7 Effct  of C/EBP Isoform Inhibition on PEPCK-C Glucoeorticoid Responsiveness 
As CEBP isoforms have been implicated in having accessory factor h c t i o n  in the 
responsiveness of the PEPCK-C promoter to glucocorticoids (see section 2.2.3.1 .I), the 
next avenue of investigation involved the characterization of the CEBP isofonn 
requirements in the glucocorticoid responsiveness of endogenous PEPCK-C. As shown 
in Fig. 4.14, cells expressing GBF-F, C/EBPa or  C/EBPP antisense RNA were treated 
with 1 pM dexamethasone for 8 hours and the levels of induction of PEPCK-C mRNA 
H4-Wl aA Bl GBF-F D4 
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Figure 4.13 The effects of CEBPa antisense RNA or GBF-F 
expression upon C/EBPP CAMP responsiveness in stable H4IIE cell 
lines. H41IE stable cell lines expressing either CEBPa antisense 
RNA (aA B1) or GBF-F (GBF-F D4) were treated with 1 rnM 8- 
CPT-cAMP for 8 hours (+); controls are designated as (-). C/EBPP 
protein levels were assessed by Western analysis as outlined in 
section 3.1 5. The equilibration of protein amount between samples 
was con.fhned by assessing the protein levels of the general 
transcription factor T F E a  (data not shown). The panel shown is 
representative of at least three independent experiments. Values 
reported are means * S.E. of three independent experiments. The 
levels of C/EBPP protein in untreated cells were arbitrarily assigned 
a value of 1. 
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Figure 4.14 The effects of CEBPa antisense RNA, CEBPQ 
antisense RNA or GBF-F expression on PEPCK-C glucocortiwid 
responsiveness in H4IIE stable cells lines in comparison to H4IIE 
wild type cells. Changes in PEPCK-C mRNA accumulation were 
assessed by ri bonuclease protection analysis as outlined in section 
3.9. Wild type H4IIE or stable H4IIE cell lines were treated with 
1 J.LM dexamethasone for 8 hours (+); controls are designated as (-). 
The equilibration of RNA amounts between samples was verified 
by RNA slot-blot analysis using an 18s rRNA probe as described 
in section 3.12 (data not shown). The above panel is representative 
of at least three independent experiments. Values reported are 
means * S.E. of four independent experiments. The levels of 
PEPCK mRNA in untreated cells were arbitrarily assigned a value 
of 1. 
were compared to that occurring in similarly treated wild type H4IIE cells. The levels of 
PEPCK-C mRNA induction in response to dexamethasone were comparable in C E B P a  
and C/EBPP antisense RNA expressing cells to that in wild type H4IIE cells with a 5-fold 
induction observed on average in these cell types. However, in GBF-F expressing cells the 
level of dexamethasone induction of PEPCK-C mRNA was somewhat inhibited in 
comparison to wild type cells, with the level of induction averaging out to approximately 
2.5-fold. 
5. DISCUSSION 
The regulation of gene expression at the level of transcription is a complex and 
multi-tiered phenomenon. Not only are genes regulated by various environmental signals 
transduced through cell-signalling pathways, which are ultimately mediated by nuclear 
transcription factors, but it is now known that the expression of transcription factors 
themselves is intricately regulated. 
One of the objectives of this research project was to contribute to the general 
understanding of how the expression of transcription factors is regulated. Specifically, the 
goal was to characterize the unique patterns of regulation of the two main hepatic CEBP 
isoforms by glucose homeostasis-affecting hormones, as well as to establish which CEBP 
isoform mediates the effects of specific hormonal signals on the gene for PEPCK-C, which 
codes for an enzyme central to glucose homeostasis. 
As the results of this thesis work have shown, the expression of CEBP isoforms 
is regulated by glucose homeostasis-affecting hormones in the liver, and the hormonal 
regulation of C/EBPa in particular appears to be distinct fiom that which occurs in other 
tissues examined to date. Furthennore, this work demonstrates the in cyto requirement for 
a specific CEBP isoforrn in the mediation of the CAMP responsiveness of the endogenous 
PEPCK-C gene, and has also generated a model cell system which can be utilized for the 
analysis of CEBP isofonn requirements in the mediation of various environmental signals 
upon the endogenous PEPCK-C gene, or potentially any other hepatic gene of interest. 
5.1 Hormonal Regulation Studies 
5.1.1 The Hormonal Regulation of CIEBPa ia Liver 
Experiments designed to characterize the patterns of hormonal regulation of CEBP 
isofonns in H4IIE cells revealed that glucocorticoids are a dominant regulator of both 
CEBPa and CEBPP expression (Figures 4.2 and 4.4). The effects of dexamethasone on 
CEBPa expression in H4IE cells appear to be cell specific. Whereas dexamethasone 
induces both C/EBPa mRNA accumulation and protein levels in H4IIE cells (Figures 4.2. 
and 4.4), it has been shown to rapidly, albeit transiently, reduce the levels of CEBPa in 
3T3 -L 1 adipoc ytes and in white adipose tissue (MacDougald, et al. 1 994). Interestingly, 
this reciprocal action of dexamethasone on gene expression between liver and adipose 
tissue is also witnessed in the regulation of PEPCK-C gene expression (Meisner, et ul. 
1 985 and Nechushtan, et al. 1 987). In studies utilizing the IEC-6 rat intestinal crypt cell 
line, dexamethasone had no observable effect upon CEBPa expression patterns 
(Boudreau, st al. 1996). Thus it would appear that the regulation of C/EBPa by 
glucocorticoids is uniquely tailored to the tissue in which it is expressed, perhaps based 
upon the metabolic roles of the constituent genes which it ham-activates. 
In addition to the effects of glucocorticoids on the expression of hepatic genes 
critical for metabolic processes, these steroid compounds are also known to inhibit cell 
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growth and division in regenerating liver and in some liver-derived cell lines (Cook, et al. 
1988). In correlation with our own findings, Ramos, ei al. (1 W6), demonstrated that the 
dexamethasone-induced expression of CEBPa is required for the glucocorticoid-mediated 
cell cycle arrest of minimal deviation rat hepatoma cells. 
8-CPT-cyclic-AMP was observed to have relatively minor effects on C/EBPa 
expression both in cyto and in vivo in comparison to its effects on C/EBPP (Figures 4.2 and 
4.5). The effects of glucagon, via CAMP, on CIEBPa expression have not been previously 
reported. While the induction of C/EBPa mRNA accumulation by 8-CPT-cAMP was 
negligible, and non-existent within adult rat liver, a small but significant induction of 
C/EBPa protein levels was routinely observed in H4IIE cells. Such a lack of correlation 
between CEBP isoform mRNA and protein levels is not uncommon and has been reported 
by Descombes, et al. (1990), who observed large differences in the ratios of C/EBPP 
rnRNA/protein levels in liver and in lung. In that study, liver tissue was seen to have lower 
levels of C/EBPP mRNA than lung, yet liver accumulated significant amounts of C/EBPP 
protein relative to lung tissue. A similar phenomenon has been observed with another 
structurally related transcription factor, the D-site binding protein (DBP), whose mRNA 
can be detected in many different tissues and yet whose protein can only be detected in 
significant amounts in liver (Mueller, et al. 1990). Thus post-transcriptional regulation of 
transcription factor expression is not uncommon, and can often account for differences 
observed between the levels of mRNA and protein. 
The effects of insulin on ClEBPa expression in H4IE cells was bi-phasic, initially 
inhibiting and then inducing its levels of mRNA in a temporal fashion (Figure 4.2). This 
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observation was extended to include parallel effects on CEE3Pa protein (Figure 4.4). The 
effects of insulin on C/EBPa expression in combination with other hormones was varied 
and seemed dependent upon the hormonal combination. The effects of insulin on CIEBPa 
expression in intestinal tissue can only be inferred indirectly h m  experiments involving 
serum treatment of rat intestinal crypt IEC-6 cells by Boudreau, et al. (1996). This study 
demonstrated a small but significant increase in CEBPa mRNA levels by some post- 
transcriptional mechanism. The reported effkcts of insulin upon C/EBPa expression in 
Illy-differentiated 3T3-L 1 adipocytes appear similar to its effects in the liver cell; however 
it appears to act far more acutely (MacDougald, et al. 1995). Differentiated 3T3-Lf cells 
treated with large doses of insulin exhibited a dramatic decrease in CEBPa  protein levels 
within 4 hours, whereas the results presented in Figure 4.4 showed that the insulin-induced 
decrease in C/EBPa protein is not observable in H4IIE cells until a 16 hour time point, 
albeit at a lower concentration of insulin. Thus it would appear that much like the effects 
of glucocorticoids upon CEBPa expression, the effects of insulin upon this transcription 
factor vary between different tissues, which again could be based on the metabolic profile 
of the tissue and the tissue-specific properties of the genes which C/EBPa is called upon 
to tram-activate. 
5.1.2 The Hormonrl Reguhtion of CJEBPP in Liver 
In general, the effects of a given hormonal treatment on CEBPP mRNA or protein 
levels were much more significant than those on CEBPu expression in regards to the fold- 
changes observed. As discussed in section 5.1.1, glucocorticoids were observed to have 
a dominant inductive effect on the expression of C/EBPP (Figures 4.2 and 4.4), much like 
what was observed with CEBPa, although this inductive effect was more profound. Our 
results correlate with the findings of Matsuno, et al. (1 996), who demonstrated a similar 
effect of dexamethasone upon CEBPP mRNA accumulation in primary-cultwed rat 
hepatocytes. However, it appears that the effects of glucocorticoids on CIEBPP expression 
in the primary hepatocyte is far more acute and transient than its effects in the H4IIE rat 
hepatoma, as Matsuno, ef al. (1 W6), observed dexamethasone-induced induction of 
CEBPP mRNA within 30 min, which peaked at 2 hours and then gradually decreased. 
Another report concerning the effects of glucocorticoids upon CEBPP expression was 
conducted in an intestinal cell line by Boudreau, et d (1996). This study revealed an 
inductive effect on C/EBPP mRNA and protein levels in these cells in response to 
dexamethasone treatment which could be accounted for by changes in the rate of 
transcriptional initiation of the C/EBPP gene. 
8-CPT-cyclic- AMP had a large inductive effect on CEBPP mRNA levels both in 
cyto and in vivo (Figures 4.2 and 4.9, and a significant acute inductive effect on C/EBPP 
proteins levels in H4UE cells (Figure 4.4). A similar effwt of CAMP on hepatic C/EBPP 
mRNA levels in vivo was reported by Park, et 41. (1 993), utilizing similar experimental 
conditions, and by Matsuno, et al. (1996), in rat primary hepatocytes. Cyclic-AMP is also 
known to strongly induce CEBPP mRNA accumulation in primary cultures of Sertoli cells 
(Gronning, et al. 1999). The effects of CAMP on CEBPP expression in other tissues has 
not been reported. 
Insulin was seen to have an inductive effect on both C/EBPP mRNA accumulation 
and protein levels in H 4 I E  cells (Figures 4.2 and 4.4). This observation correlates with 
the observed insulin-mediated induction of CEBPP mRNA and protein levels in rat 
intestinal IEC-6 cells (Boudreau, ef a/. 1996), and in Mly differentiated 3T3-L1 cells 
(MacDougald, et al. 1995). However, a report by Bosch, ef al. (1 995), contrasts with our 
findings, demonstrating an insulin-mediated decrease in CfEBPf3 protein levels in adult 
mouse liver. Although our own results have demonstrated a parallel increase in both 
CEBPP mRNA and protein levels in response to prolonged insulin treatment in cyto, the 
results of Bosch, et al. (1995), may more clearly reflect the effects of insulin on the 
CIEBPP gene product in vivo. 
Thus, it appears that the effects of certain glucose homeostasis-affecting hormones 
upon CIEBPP expression are conserved between different metabolically relevant tissues, 
d i k e  the uniquely tissue-specific regulation of CEBPa by the same hormones. 
These observations offer support to the hypothesis presented by McKnight, et al. (1 989), 
who have suggested that the a-isoforrn of CIEBP is a central regulator of energy 
homeostasis. If in fact C/EBPa is such a "central regulator", its expression patterns would 
have to be uniquely tailored to suit the metabolic role of a given tissue in regards to the 
overall hormonal environment within the organism at any given time. Regulation of 
C/EBPa expression would have to occur such that it would be capable of the Pam- 
activation of metabolically relevant genes within appropriate tissue-specific and temporal 
guidelines. 
5.13 The Effkcb of StreptozotocBDiabetes on C/EBPa Expression 
Experiments designed to ascertain the effects of an experimental type I diabetic4 ike 
state on hepatic CEBP isoform expression revealed a complex alteration in the expression 
of ClEBPa in diabetic rat liver (Figures 4.6 and 4.7). While streptozotocin diabetes was 
observed to decrease hepatic C/EBPa mRNA levels (Figure 4.6), an effect which was 
partially reversible by insulin treatment, the effects upon the two major translation forms 
of C/EBPa (section 2.3.1.3) were diverse (Figure 4.7). The levels of  the 29 kDa form of 
CEBPa were decreased relative to the Mi-length 42 kDa protein form in diabetic livers, 
suggesting a shift towards the preferential usage of the first AUG of  the C/EBPa mRNA 
to initiate translation by an unknown molecular mechanism. A decrease in C/EBPa protein 
levels has also been observed in the kidneys of streptozotocin-treated rats, although no 
information regarding changes in specific C/EBPa translation forms was presented in that 
particular study (Zador, er al. 1998). A study similar to our own by Valera, et of. (1993), 
contradicted our findings, reporting a small increase in C/EBPa mRNA levels in rat 
streptomtocin-diabetic liver. A possibility for this inconsistency could be the differences 
in the streptozotocin dose utilized to induce the diabetic state, or possibly differences in the 
severity and/or duration of the diabetes. It should be noted that our own findings 
demonstrated correlating changes in both CEBPa rnRNA and protein levels, whereas the 
work of Valera, et al. (1 993), only examined diabetes-induced changes in C/EBPa mRNA 
leveIs. 
Given the differences in tram-activational ability between the two C/EBPa 
tramlation forms (Friedman and McKnight ( 1 ! N O )  and Pei and Shih (1 99 1 )), an increase 
in the ratio of one f o m  to the other could have a significant effect on the overall tram- 
activational ability of C E B P a  in the streptozotocin-diabetic rat liver. The 29 kDa 
translation form of CEBPa  lacks the N-terminal 1 17 residues of the firll-length form, 
which corresponds to the tram-activation domain, and thus is transcriptionally less active. 
The CEBPa 29 kDa form does, however, possess the DNA-binding and dimerimtion 
domains, which allows it to form less active heterodimers with Ill-length 42 kDaCEBPa. 
Given the increase in the ratio of active 42 kDa CEBPa to inactive 29 kDa CEBPa in 
streptozotocin-diabetic rat liver, an overall increase in the tram-activational activity of 
CEBPa in diabetic liver could potentially occur. 
It should be noted that distinct differences in CEBP isoform translation form 
expression have also been observed under acute phase response conditions (An, et al. 
1 W6), and in 3T3-L 1 cells after treatment with thiazolidinediones (Hemati, et al. 1998). 
Although recent work by Lincoln, et al. ( 1 W8), suggested that the generation of truncated 
CEBPa and C/EBPP translation forms is due to proteolytic degradation and not due to a 
translational start site multiplicity model, our own results and those of An, et ale (1996), 
and Hemati, et al. (1998), suggest a physiological role for alternate C/EBP translation 
forms. In addition, our own experience has shown that although truncated forms of 
C E B P a  and C/EBPP are expressed at low levels within H4ItE cells, these alternate forms 
can still by detected by Western analysis when using similar lysis buffer conditions as those 
utilized by Lincoln, et al. (1998), which should otherwise prevent the formation of 
proteolytic products (data not shown). These findings suggest that the relative levels of the 
different CEBP translation forms can be di fferentid 1 y regulated by changes in cellular 
physiology, and that these changes may play a role in defining the tram-activational 
properties of  CEBP isoforms in these altered physiological states. 
Due to the complex nature of most gene promoters, it is difficult to make 
generalized statements regarding the consequences of altered C/EBPa expression during 
diabetes on overall hepatic gene expression and any possible correlation with the metabolic 
and physiological perturbations which occur in this disease state. Although it is difficult 
to assess how the changes in expression of this single transcription factor during diabetes 
might affect the overall physiological state of the organism, it is certain that C/EBPa does 
play a pivotal role in metabolism. Knockout of the C E B P a  gene has demonstrated the 
absolute requirement of this transcription factor for proper glycogen metabolism and 
developmental expression of pace-setting gluconeogenic enzymes including PEPCK-C 
(Wang, ef al. 1995). Disruption o f  the debpa gene in adult mice by the loxP / Cre 
recombinase methodology has also demonstrated the requirement of this factor in bilirubin 
detoxification and gluconeogenesis (Lee, er al. 1997). Work by Roesler, er al. (1 996 and 
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1998b), as well as results presented in section 4.2 of this thesis, have demonstrated the 
requirement of C/EBPa in the maintenance of basal expression and mediation of  the CAMP 
responsiveness of PEPCK-C gene transcription. Thus it appears that C/EBPa is an 
important regulator of hepatic carbohydrate metabolism, and changes in its expression 
which occur in streptozotocin-diabetes could have significant effects upon these metabolic 
processes which may ultimately contribute to the overall diabetic phenotype. 
5.2 Discussion of PEPCK-C Gene Expression - C/EBP Isoform Requirement Studies 
Experiments designed to determine the C/EBP isoform absolutely required to 
mediate the CAMP responsiveness of endogenous PEPCK-C in hepatoma cells have 
identified C/EBPa as this essential factor (Figure 4.1 2). Furthermore, the general 
requirement for C/EBP isoforms in the mediation of the PEPCK-C glucocorticoid 
response, potentially as accessory factors, has been confirmed. It would also appear that 
the exact identity of the CEBP isoform required to participate in the PEPCK-C 
glucocorticoid response is functionally redundant based on the representative data 
presented in Figure 4.14. In order to conduct the above experimental work a number of rat 
hepatoma H4IIE stable cell lines were produced which serve as model systems to study the 
effects of general or specific CEBP isoform inhibition upon endogenous gene expression 
and regulation. 
5.2.1 The Effects on C/EBP Isoform Expression in Stable Rat Hepatoma H4IIE Cell 
Lines 
5.2.1.1 The Effkcts of Stable GBF-F Expr~ssion on C/EBP Isoform Expression 
The stable expression of the CEBP isoform dominant negative molecule GBF-F 
appears to have significant effects on CEBP isofom gene expression, most especially on 
that of CEBPa (Figure 4.8). While affecting the mRNA levels of both hepatic CEBP 
isoforms, the stable expression of GBF-F appears to have effects on the protein level of the 
a-isoform only. Unlike CEBPa protein, CEBPP protein appears d a t e d  by stable 
GBF-F expression. As has been mentioned previously, it is not uncommon for differential 
regulation of CEBP isoform mRNA and protein levels to be observed (section 5.1.1). No 
published data has been reported to date which supports the concept of transcriptional 
regulation of the C/EBPP gene by CEBP isoforms, although this possibility is not unlikely 
considering the known regulation of the C/EBPa gene promoter by CEBP isoforms. 
The observation that GBF-F stable expression inhibited overall C/EBPa expression 
is not particularly surprising given the recognized auto-regulation of the C/EBPa gene in 
mouse and human (section 2.3.2). The murine CEBPa promoter is known to bind the 
C/EBPa protein directly (Christy, et of. 1991 and Legraverend, et al. 1993), and in 
transient transfection studies expression of C/EBPa has been shown to trans-activate co- 
expressed ClEBPa promoter-luci ferase reporter constructs. The studies of Legraverend, 
el of. (1993), have also shown tram-activation of similar promoter constructs when co- 
transfected with CIEBPP expression vector but to a far lesser extent than experiments 
conducted with C/EBPu vectors. The work of Timchenko, et al. (1995), has also 
suggested a role of C/EBPa in auto-regulation of its own gene in humans. However, this 
study concluded that there was no direct binding of the C/EBPa protein to its promoter, 
rather that its effects were in some manner exerted through another binding protein termed 
the upstream stimulatory factor (USF). In whatever event, the auto-regulatory effects of 
C/EBPu on its own promoter have been established in two different species; unfortunately 
no information regarding the regulatory properties of the CIEBPa gene in rat has been 
reported. It would not, however, seem unlikely that similar mechanisms could occur in the 
rat and the results presented in section 4.2.1 of this thesis support this hypthesis. Given 
the down regulation of C/EBPQ mRNA accumulation in the GBF-F D4 cell line, it is also 
possible to hypothesize that the promoter of the rat CIEBPQ gene may also be responsive 
to the tram-activational properties of CEBP isoforms. 
An important consideration in the interpretation of the results of section 4.2.1 is a 
possible flaw in the design of the dominant negative GBF-F molecule. It has been 
suggested that although it is certainly capable of forming inactive heterodimers with CIEBP 
isoforms, the GBF-F molecule may also form similar inactive heterodimers with fos and 
jun (personal communication between W.J. Roesler and C.R. Vinson). Although unlikely 
to cause potential misinterpretation of data which suggest effects on the expression of 
CEBPa by GBF-F expression, as no known fodjun binding sites are thought to occur in 
the CIEBPa promoter, non-specific inhibition of fodjun as well as CEBP isofonns wuld 
effect interpretation of data regarding its affects on the expression and regulation of other 
genes, including PEPCK-C. This concept will be considered fhrther in section 5.2.2. 
5.2.1.2 The Effects of Stable C/EBPa Antisense RNA on C/EBP Isofonn Expression 
The stable expression of specific antisense RNA to the a-isoform of C/EBP in the 
aA B1 H4IIE cell line appears to have significant effects upon the expression of both 
major hepatic CEBP isoforms (Figure 4.9). Expression of C E B P a  antisense RNA had 
potent effects on both C/EBPa mRNA and protein levels. The approximately 80% 
reduction in C/EBPa mRNA and protein levels in the aA B1 cell line in comparison to 
wild type H4IIE cells is comparable to the inhibition observed by Lin and Lane, (1992), 
when they expressed a similar CIEBPa antisense RNA in 3T3-L 1 adipocytes. The segment 
of the C E B P a  sequence utilized to produce antisense RNA by Lin and Lane, (1 992), was 
chosen so as to insure as much specificity for the a-isoform of C/EBP as possible. The 
approximately 400 bp region of CEBPa sequence utilized by these researchers 
corresponded to the tram-activation domain and was positioned far 5' to the conserved 
basic region and leucine zipper of CEBP isoforms. The region of C/EBPa sequence 
utilized in this thesis work was approximately 250 bp larger, but corresponded to an 
encompassing region of sequence which was still unique to the a-isofom of C/EBP. 
Correlating with our observations, the work of Lin and Lane, (1 992), also demonstrated an 
inhibition in the levels of C/EBPa mRNA as a result of antisense expression. This 
inhibition was explained by these workers as being a consequence of their measured 
inhibition of the transcription rate of the C E B P a  gene. These workers postulated that this 
inhibition of C/EBPa transcription rate was perhaps brought about by a lack of auto- 
regulation by its own protein as a consequence of the antisense expression which could 
bring about decreased protein levels via  an increased turnover of CEBPa  mRNA or 
inhibition of C E B P a  mRNA translation. This work, which appeared prior to the 
description of the auto-regulation of the C/EBPa gene, was the first instance of such a 
phenomenon being proposed. Interestingly, although never displaying any data, the work 
of Lin and Lane, (1 992)- also suggested that the expression of antisense RNA to C/EBPa 
did not affect the levels of C/EBPP mRNA. The results of Lee, et al. (1 997), in which 
C/EBPa was conditionally knocked-out in adult mice v ia  the CreAoxP recombination 
system, also indicated no change in C/EBPP mRNA levels as a result of the down 
regulation of the a-isoform of CEBP. These observations are not in agreement with our 
observations in rat hepatoma H 4 E  cells where we observed a doubling of both C/EBPP 
mRNA and protein as a consequence of antisense C/EBPa RNA expression (Figure 4.9). 
The fact that we were able to detect an increase in C/EBPP mRNA levels in our CEBPa 
antisense RNA expressing cell line may merely be a consequence of our use of the more 
sensitive ribonuclease protection analysis technique for determining changes in mRNA 
accumulation. As already presented, the changes in CIEBPP mRNA were parallelled by 
an increase in the levels of C/EBPP protein as well. Our observation of an increase in 
CEBPP expression along with down-regulation of C/EBPa may help lend support to the 
observations of Wang, ef at. (1995), who reported an interesting discrepancy. These 
researchers observed an almost total inhibition of PEPCK-C rnRNA in the livers of 
newborn CEBPa neonatal knockout mice, but after 7 hours post-parturn the levels of 
PEPCK-C climbed back to control values. It was the opinion of these workers that other 
members of the C/EBP family such as C/EBPP, might be capable of substituting for 
CEBPa at these later time points so as to reestablish the levels of PEPCK-C expression. 
This would certainly be a possibility if a molecular mechanism exists to cause the levels 
of CEBPP expression to undergo a compensatory rise as a result of the down-regulation 
of CEBPa. Currently no clear information exists concerning the potential regulation of 
the CEBPB gene promoter by other CEBP isoforms, but given the data presented in this 
thesis work, which has been discussed in this section and in section 5.2.1 .I, it is proposed 
that this might occur. 
5.2.13 The Effeets of Stable C/EBPP Antisense RNA on C/EBP Isoform Expression 
The stable expression of antisense RNA specific for the P-isofom of C/EBP also 
had significant effects on the expression of the two main hepatic CEBP isoforms (Figure 
4.10). The expression of C/EBPP antisense RNA in the PA C4 H4IE cell line produced 
significant decreases in both C/EBPP mRNA and protein levels. Whether the decrease in 
C/EBPP mRNA levels in the PA C4 cell line relative to controls is due to increased 
susceptibility of C/EBPP transcripts to nuclease digestion, brought about by formation of 
duplex with its antisense RNA, or is due to a potential lack of auto-regulation of the 
CEBPP gene by its own protein as seems to occur in the case of the C/EBPa gene, is 
uncertain. As already stated, no clear evidence exists regarding the regulation of the 
C/EBPP gene by CEBP isoforms, although such a mechanism has been at least suggested 
in the literature and the results of this thesis work would certainly lend support to this 
hypothesis. A possible avenue of future investigation into potential auto-regulatory 
properties of the CEBPP gene would involve measuring the basal transcription rate of this 
gene in the PA C4 H4IIE cell line in comparison to that in wild type H4IIE cells. The 
levels of C/EBPa protein are significantly increased in the PA C4 cell line relative to wild 
type cells. This inductive effkct on the "opposing" C/EBP isoform in a cell line expressing 
antisense RNA to a given isofonn is similar to that observed in the aA B1 cell. This effect 
might again be some sort of compensatory mechanism which serves either to maintain or 
balance the levels of the two main hepatic CEBP isoforms in the liver cell. However, 
unlike the effect on C/EBPP expression observed in the a A  B 1 cell which appears to be 
at least primarily at the level of its mRNA, the effects upon CEBPa expression in the PA 
C4 cell appeared to be due to a post-transcriptional upregulation of CEBPa protein levels. 
No change in the levels of C/EBPa mRNA in the PA C4 cell line relative to wild type 
H4IIE cells were ever observed, however a consistent upregulation of its protein did occur. 
Post-transcriptional regulation of CEBP isoform expression by another CEBP protein has 
recently been reported in two articles arising from related research groups. The work of 
Burgess-Beusse, et uI. (1999), reported that the induction of C/EBPa expression in 
cultured liver cells leads to an increase in LIP, an alternate translation form of C/EBPP 
(section 2.3.1.3). The work of Welm, et ai. (1 999 ,  has firrther expanded upon this 
observation and reported that CEBPa-induced production of the LIP form of C/EBPQ 
occurred as a result of a post-translational proteolytic cleavage of full length C/EBPP. 
Although not directly correlated with our own observations, the work of Burgess-Beusse, 
et uf. (1999), and Welm, et ai. (1 999), do complement our findings if it is hypothesized that 
some form of reciprocal post-transcriptional regulation occurs to control the levels of 
C/EBPa and C/EBPP protein in the liver. A rise in C/EBPa protein levels appears to 
induce a decrease in the more transcriptionally active form of C/EBPP, and based on our 
own findings it seems that an induced decrease in C/EBPP protein levels can bring about 
an upregulation in the full length form of CEBPa. It would be an interesting fbture 
prospect to more closely examine the ratios of C/EBP isoform alternate translation 
products within antisense expressing H I E  cell lines to attempt to uncover more 
information regarding a mechanism by which an alteration in the expression of one CEBP 
isoform might bring about reciprocal post-transcriptional changes in the expression and 
transcriptional activity of the other. 
5.2.2 The Role of C/EBP Isoforms in the Mediation of the CAMP Responsiveness of 
PEPCK-C 
The results presented in Figure 4.12 have dearly defined C/EBPa as the isoform 
required for the CAMP responsiveness of the endogenous PEPCK-C gene in rat hepatoma 
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H4IIE cells. This observation is supported by the lack of CAMP induction of PEPCK-C 
in both the GBF-F D4 and aA B 1 cell lines and the robust CAMP response which can still 
occur in the PA C4 cell line. Further support of this hypothesis that CEBPa is the 
regulator of PEPCK-C CAMP responsiveness is derived from the observation that the 
levels of CEBPa protein were reduced in the GBF-F D4 cell line (Figure 4.8), in which 
PEPCK-C CAMP responsiveness was abolished, in addition to the fhctional inhibition 
upon CEBP isofom transcriptional activity which exists due to GBF-F expression in these 
cells. Also in support of this hypothesis, the levels of C/EBPP protein were significantly 
increased in the aA B1 cell line (Figure 4.9), and yet no response of PEPCK-C to CAMP 
was generated (Figure 4.12). Furthermore, the levels of CIEBPa protein were considerably 
elevated in the FA C4 cell line (Figure 4.10) in which a consistent and significant increase 
in the CAMP responsiveness of PEPCK-C was observed. There appears to be no global 
inhibition of CAMP signalling in either the aA B1 or GBF-F D4 cell lines as indicated by 
the CAMP induction of the CEBPP gene which was comparable to that seen in wild type 
H4UE cells (Figure 4.13). As discussed in section 5.2.1 .l, the possibility that the 
expression of GBF-F also inhibits fodjun activity must be considered in the interpretation 
of the above data since the fodjun heterodimer API is an active factor in the PEPCK-C 
promoter's CRU, being required to mediate the synergy between CRE-1 and the LSR 
(section 2.2.3.1.3). However, given the effects of CEBPa antisense RNA on PEPCK-C 
CAMP responsiveness, this possibility does not weigh greatly upon the interpretation of 
which CEBP isoforrn is required to mediate the response. Thus the requirement for the 
a-isoforrn of CEBP in this hormonal response of the PEPCK-C promoter is strongly 
supported by the data presented in section 4.2 of this thesis. 
Although not addressing the role of  C E B P a  in the regulation of the PEPCK-C 
gene by CAMP, the work of Wang, et a/. (1 995) and Lee, et a1. (1 997) demonstrated the 
requirement of C E B P a  for the basal expression of PEPCK-C (supported by Figure 4.12). 
Interestingly, both studies have demonstrated a potential difference in the developmental 
requirement of C E B P a  for PEPCK-C basal expression. As mentioned in section 5.2.1.2, 
the expression of PEPCK-C is initially delayed in the neonatal knockout mice of  Wang, 
et al. (1 999,  but appears several hours post-parturn and slowly rises back to normal levels. 
This observation suggests that the role of  C/EBPu in maintaining PEPCK-C basal 
expression levels can be eventually substituted for by another transcription factor several 
hours after birth, perhaps C/EBPP as has been suggested in the literature and which may 
be supported by our own findings as discussed above. However, the results of Lee, et ol. 
(1997), showed that PEPCK-C basal expression is still strongly inhibited in the adult 
conditional C/EBPa knockout animal, suggesting that any sort of fimctional compensation 
for the loss of C/EBPa in knockout animals is not sustainable. Interestingly, the levels of 
CEBPP mRNA were not elevated in either neonatal or adult C/EBPa knockout models, 
although the levels of  C/EBPP protein were not measured. These observations do not 
correlate with our observation of increased C/EBPP mRNA and protein levels in stable 
H4IIE cells expressing C/EBPa antisense RNA (Figure 4.9), and may suggest important 
developmental regulatory mechanisms which exist in vivo. 
As a final point of support for our observations concerning the absolute requirement 
of CEBPa in PEPCK-C CAMP responsiveness, adult knockout of CEBPP has been 
shown to have no effect on the basal expression or CAMP inducibility of PEPCK-C (Liu, 
et al. 1999, which is in total agreement with our findings presented in Figure 4.12. 
5.2.3 The Role of CEBP Isoforms in the Mediation of the Glucocorticoid 
Responsiveaess of PEPCK-C 
The results presented in Figure 4.14 of this thesis suggest a general requirement of 
CEBP isoforms in the mediation of the glucocorticoid responsiveness of the endogenous 
PEPCK-C gene in rat hepatoma H4IIE cells. While specific antisense RNAs to C/EBPa 
or CEBPP did not significantly affect the response of PEPCK-C to dexamethasone, 
expression of GBF-F reduced this response by approximately 50%. This suggests a general 
requirement for CEBP isofoms in this response, dthough a specific CEBP isofom may 
not be required based on the observations made in the antisense RNA expressing cell lines. 
These observations correlate well with the recently identified role of CEBP isoforms as 
accessory factors for the PEPCK-C glucocorticoid response. Although it has been 
suggested that C/EBP isoforms may affect glucocorticoid responsiveness of PEPCK-C by 
acting through the AF2 ciselement (section 2.2.3.1. I), recent evidence suggests that this 
is likely not the case (Wang. et ell. 1996). Rather it appears that C/EBP isoforms binding 
to the PEPCK CRE-1 may be involved as deletion of this region of the promoter can 
reduce glucocorticoid responsiveness by 50% (Imai, et al. 1993). Recent work by Yamada, 
et ul. (1 999), based on synthetic promoter constructs and GALA-hion protein expression, 
suggested that CEBPP may be the specific accessory factor which aids in the mediation 
of the glucocorticoid response through the PEPCK-C CRE- 1. Although the data presented 
herein suggests that either CEBP isofonn can participate, they generally support the 
hypothesized involvement of CEBP isoforms in this transcriptional response of the 
PEPCKC gene to glucocorticoids and does perhaps more accurately reflect endogenous 
regulatory mechanisms. 
Finally, the data presented in Figure 4.14 showing the glucocorticoid 
responsiveness of PEPCK-C in stable H 4 I E  cell lines in comparison to wild type cells, 
taken in combination with results shown in Figures 4.12 and 4.13, showing the CAMP 
responsiveness of PEPCK-C in stable H4IIE cell lines in comparison to wild type cells and 
the CAMP responsiveness of the C/EBPP gene in the aA B1 and GBF-F D4 cell lines, 
respectively, indirectly support the concept that the production of the H 4 I E  cell line 
models by stable tmnsfection protocols has not affected global hormonal signalling. 
53 Concluding Remarks 
The results presented in this thesis provide a significant contribution to the 
understanding of the regulation of CEBP isoforms in a liver background and have 
identified the CEBP isofonn required to mediate CAMP responsiveness of the endogenous 
PEPCK-C gene in liver. Furthennore, genetically modified rat hepatoma cells have been 
produced which can be utilized to assess the requirements of CEBP isofoms in various 
endogenous molecular mechanisms present within the liver cell. 
This thesis work has demonstrated the tissue-specific nature of the regulation of 
CEBPa by hormones which correlates well with its role as a tram-activator of many 
metabolically important genes whose expression patterns are regulated by many of the 
same hormones, and in many cases which must be uniquely tailored to the metabolic 
profile of a given tissue. This work has also demonstrated an unique alteration in the 
tram-activational activity of C/EBPa in the iivers of  streptozotocindiabetic rats, which 
may prove useful in accounting for changes in the expression of genes regulated by 
CEBPa which occur in the diabetic state. 
The production of stable rat hepatoma H4IIE cell lines expressing molecules 
designed to inhibit the activity of CEBP isofonns has provided for the assessment of the 
requirement of these transcription factors in various cellular processes. This thesis work 
has also demonstrated the need to build upon synthetically-based in cpo studies with 
experiments which can perhaps more accurately characterize endogenous molecular 
mechanisms, given the fact that experiments based on more artif cia1 systems can only 
provide initial information regarding the potential for a given molecular mechanism to 
occur. In combination with in vivo based studies, cell culture based experiments directed 
towards endogenous genes can serve well to elucidate the complexity of regulational 
mechanisms within the intact cell. 
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